{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:44:36Z","timestamp":1794437076366,"version":"4.9.1"},"reference-count":328,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR\u2013M4C2\u2013l1.3 Project PE00000019 \u2018HEAL ITALIA\u2019 CUP B73C22001250006"],"award-info":[{"award-number":["PNRR\u2013M4C2\u2013l1.3 Project PE00000019 \u2018HEAL ITALIA\u2019 CUP B73C22001250006"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN Progetti di Rilevante Interesse Nazionale 2022 Prot. 2022J8X7PJ"],"award-info":[{"award-number":["PRIN Progetti di Rilevante Interesse Nazionale 2022 Prot. 2022J8X7PJ"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["MSCA-DN N. 101119464"],"award-info":[{"award-number":["MSCA-DN N. 101119464"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["MFAG (28761)"],"award-info":[{"award-number":["MFAG (28761)"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer stem cells (CSCs) drive tumour initiation, progression, metastasis, and therapy resistance through their remarkable plasticity, enabling dynamic transitions between stem-like and differentiated states. A pivotal mechanism underlying this plasticity is epithelial-mesenchymal plasticity (EMP), which encompasses epithelial-mesenchymal transition (EMT), partial or hybrid EMT (E\/M) states, and mesenchymal-epithelial transition (MET), allowing cancer cells to acquire invasive, stem-like properties while maintaining proliferative potential. Unlike the traditional binary view of EMT, recent evidence reveals a spectrum of intermediate E\/M phenotypes that exhibit increased tumorigenicity, metastatic potential, and therapy resistance. This plasticity is orchestrated by intricate regulatory networks involving EMT-inducing transcription factors, signalling pathways, and non-coding RNAs. The tumour microenvironment (TME), with its cellular and non-cellular components, provides critical extrinsic cues that stabilize E\/M states. Notably, metabolic reprogramming cooperates with EMP. Indeed, E\/M flexibly shifts between glycolysis, oxidative phosphorylation, and lipid metabolism alterations to fuel invasion, buffer oxidative stress, and evade ferroptosis. Advanced and recently developed in vitro and in vivo models have illuminated these dynamics: dual-fluorescent reporters, microfluidic tumour-on-a-chip, genetically engineered mouse models, bioluminescence imaging, and intravital microscopy enable real-time tracking of EMP during progression and therapy response. On the other side, in silico tools, single-cell\/spatial transcriptomics, network inference, machine learning, and agent-based modelling, map hybrid states, predict trajectories, and help identify biomarkers, revealing EMP\u2019s role in evolutionary fitness. Therapeutically, targeting EMP holds promise to target resistant cancer cells and prevent relapse, though challenges arise from redundancy and plasticity. Strategies include pathway inhibitors, metabolic disruptors, epigenetic agents, TME modulators, and differentiation inducers. Combination therapies, guided by EMP biomarkers and rational models, act in combination with standard treatments to lock cells in epithelial states, disrupt hybrid phenotypes, and overcome resistance. This review highlights EMP as the main driver of tumour evolution, offering a unified framework for understanding tumour heterogeneity and heterogeneity-driven failures in therapy. By elucidating molecular mechanisms and vulnerabilities, it paves the way for precision interventions that could transform outcomes in aggressive malignancies, ultimately restraining metastasis and recurrence.<\/jats:p>","DOI":"10.1186\/s12943-026-02690-x","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:12:59Z","timestamp":1779707579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hallmarks of epithelial-mesenchymal plasticity in cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Laurie","family":"Clauzon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Verona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiya","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella Roberta","family":"Brancato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Di Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Di Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Stassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Di Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"2690_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730\u20137. https:\/\/doi.org\/10.1038\/nm0797-730.","journal-title":"Nat Med"},{"key":"2690_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fmolb.2020.00079","volume":"7","author":"AP Thankamony","year":"2020","unstructured":"Thankamony AP, Saxena K, Murali R, Jolly MK, Nair R. Cancer stem cell plasticity - a deadly deal. Front Mol Biosci. 2020;7:79. https:\/\/doi.org\/10.3389\/fmolb.2020.00079.","journal-title":"Front Mol Biosci"},{"key":"2690_CR3","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/cancers12061436","volume":"12","author":"A Turdo","year":"2020","unstructured":"Turdo A, Porcelli G, D\u2019Accardo C, Franco SD, Verona F, Forte S, et al. Metabolic escape routes of cancer stem cells and therapeutic opportunities. Cancers (Basel). 2020;12:1436. https:\/\/doi.org\/10.3390\/cancers12061436.","journal-title":"Cancers (Basel)"},{"key":"2690_CR4","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.3390\/jcm11236996","volume":"11","author":"M Lo Iacono","year":"2022","unstructured":"Lo Iacono M, Gaggianesi M, Bianca P, Brancato OR, Muratore G, Modica C, et al. Destroying the shield of cancer stem cells: natural compounds as promising players in cancer therapy. JCM. 2022;11:6996. https:\/\/doi.org\/10.3390\/jcm11236996.","journal-title":"JCM"},{"key":"2690_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"J-J Loh","year":"2024","unstructured":"Loh J-J, Ma S. Hallmarks of cancer stemness. Cell Stem Cell. 2024;31:617\u201339. https:\/\/doi.org\/10.1016\/j.stem.2024.04.004.","journal-title":"Cell Stem Cell"},{"key":"2690_CR6","doi-asserted-by":"publisher","first-page":"101043","DOI":"10.1016\/j.gendis.2023.05.024","volume":"11","author":"Q Guo","year":"2024","unstructured":"Guo Q, Zhou Y, Xie T, Yuan Y, Li H, Shi W, et al. Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting. Genes Dis. 2024;11:101043. https:\/\/doi.org\/10.1016\/j.gendis.2023.05.024.","journal-title":"Genes Dis"},{"key":"2690_CR7","doi-asserted-by":"publisher","first-page":"702642","DOI":"10.3389\/fonc.2021.702642","volume":"11","author":"M Gaggianesi","year":"2021","unstructured":"Gaggianesi M, Di Franco S, Pantina VD, Porcelli G, D\u2019Accardo C, Verona F, et al. Messing up the cancer stem cell chemoresistance mechanisms supported by tumor microenvironment. Front Oncol. 2021;11:702642. https:\/\/doi.org\/10.3389\/fonc.2021.702642.","journal-title":"Front Oncol"},{"key":"2690_CR8","doi-asserted-by":"publisher","first-page":"100845","DOI":"10.1016\/j.tranon.2020.100845","volume":"13","author":"K Saxena","year":"2020","unstructured":"Saxena K, Jolly MK, Balamurugan K. Hypoxia, partial EMT and collective migration: emerging culprits in metastasis. Transl Oncol. 2020;13:100845. https:\/\/doi.org\/10.1016\/j.tranon.2020.100845.","journal-title":"Transl Oncol"},{"key":"2690_CR9","doi-asserted-by":"publisher","first-page":"1227884","DOI":"10.3389\/fonc.2023.1227884","volume":"13","author":"GM Abd","year":"2023","unstructured":"Abd GM, Laird MC, Ku JC, Li Y. Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise. Front Oncol. 2023;13:1227884. https:\/\/doi.org\/10.3389\/fonc.2023.1227884.","journal-title":"Front Oncol"},{"key":"2690_CR10","doi-asserted-by":"publisher","first-page":"11254","DOI":"10.1158\/0008-5472.CAN-07-2253","volume":"67","author":"AM Eastham","year":"2007","unstructured":"Eastham AM, Spencer H, Soncin F, Ritson S, Merry CLR, Stern PL, et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res. 2007;67:11254\u201362. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-2253.","journal-title":"Cancer Res"},{"key":"2690_CR11","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1172\/JCI38019","volume":"119","author":"H Acloque","year":"2009","unstructured":"Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119:1438\u201349. https:\/\/doi.org\/10.1172\/JCI38019.","journal-title":"J Clin Invest"},{"key":"2690_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15:129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8.","journal-title":"J Hematol Oncol"},{"key":"2690_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11010-024-04995-1","volume":"480","author":"ZU Din","year":"2025","unstructured":"Din ZU, Cui B, Wang C, Zhang X, Mehmood A, Peng F, et al. Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy. Mol Cell Biochem. 2025;480:103\u201318. https:\/\/doi.org\/10.1007\/s11010-024-04995-1.","journal-title":"Mol Cell Biochem"},{"key":"2690_CR14","doi-asserted-by":"publisher","first-page":"e70081","DOI":"10.1002\/iub.70081","volume":"78","author":"A Singh","year":"2026","unstructured":"Singh A, Gupta R, Kulshreshtha R. Capturing the variations in mutant p53-driven regulatory networks in breast cancer subtypes, its clinical relevance and a novel association with androgen receptor and EMT. IUBMB Life. 2026;78:e70081. https:\/\/doi.org\/10.1002\/iub.70081.","journal-title":"IUBMB Life"},{"key":"2690_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.12.049","author":"D Hanahan","year":"2026","unstructured":"Hanahan D. Hallmarks of cancer\u2014Then and now, and beyond. Cell. 2026. https:\/\/doi.org\/10.1016\/j.cell.2025.12.049. S0092867425014989.","journal-title":"Cell"},{"key":"2690_CR16","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41580-021-00428-9","volume":"22","author":"J Yang","year":"2021","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Author Correction: Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2021;22:834. https:\/\/doi.org\/10.1038\/s41580-021-00428-9.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2690_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.tcb.2015.07.012","volume":"25","author":"X Ye","year":"2015","unstructured":"Ye X, Weinberg RA, Epithelial-Mesenchymal Plasticity. A Central regulator of cancer progression. Trends Cell Biol. 2015;25:675\u201386. https:\/\/doi.org\/10.1016\/j.tcb.2015.07.012.","journal-title":"Trends Cell Biol"},{"key":"2690_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.stem.2014.01.009","volume":"14","author":"M Todaro","year":"2014","unstructured":"Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, Biffoni M, et al. CD44v6 Is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell. 2014;14:342\u201356. https:\/\/doi.org\/10.1016\/j.stem.2014.01.009.","journal-title":"Cell Stem Cell"},{"key":"2690_CR19","doi-asserted-by":"publisher","first-page":"1038841","DOI":"10.3389\/fcell.2022.1038841","volume":"10","author":"A Canciello","year":"2022","unstructured":"Canciello A, Cerver\u00f3-Varona A, Peserico A, Mauro A, Russo V, Morrione A, et al. In medio stat virtus: Insights into hybrid E\/M phenotype attitudes. Front Cell Dev Biol. 2022;10:1038841. https:\/\/doi.org\/10.3389\/fcell.2022.1038841.","journal-title":"Front Cell Dev Biol"},{"key":"2690_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/1878-0261.12084","volume":"11","author":"MK Jolly","year":"2017","unstructured":"Jolly MK, Tripathi SC, Somarelli JA, Hanash SM, Levine H. Epithelial\/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding? Mol Oncol. 2017;11:739\u201354. https:\/\/doi.org\/10.1002\/1878-0261.12084.","journal-title":"Mol Oncol"},{"key":"2690_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcancer.2023.02.001","volume":"90","author":"J Verstappe","year":"2023","unstructured":"Verstappe J, Berx G. A role for partial epithelial-to-mesenchymal transition in enabling stemness in homeostasis and cancer. Semin Cancer Biol. 2023;90:15\u201328. https:\/\/doi.org\/10.1016\/j.semcancer.2023.02.001.","journal-title":"Semin Cancer Biol"},{"key":"2690_CR22","doi-asserted-by":"publisher","first-page":"114284","DOI":"10.1016\/j.isci.2025.114284","volume":"29","author":"P Den Hollander","year":"2026","unstructured":"Den Hollander P, Castaneda M, Vasaikar SV, Maddela JJ, Gould C, Demestichas BR, et al. EMT-induced stem cell and mesenchymal programs can be decoupled via cell division and ESRP1-dependent mechanisms. iScience. 2026;29:114284. https:\/\/doi.org\/10.1016\/j.isci.2025.114284.","journal-title":"iScience"},{"key":"2690_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT Transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29:212\u201326. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001.","journal-title":"Trends Cell Biol"},{"key":"2690_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","volume":"21","author":"AW Lambert","year":"2021","unstructured":"Lambert AW, Weinberg RA. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat Rev Cancer. 2021;21:325\u201338. https:\/\/doi.org\/10.1038\/s41568-021-00332-6.","journal-title":"Nat Rev Cancer"},{"key":"2690_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fonc.2015.00155","volume":"5","author":"MK Jolly","year":"2015","unstructured":"Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, et al. implications of the hybrid epithelial\/mesenchymal phenotype in metastasis. Front Oncol. 2015;5:155. https:\/\/doi.org\/10.3389\/fonc.2015.00155.","journal-title":"Front Oncol"},{"key":"2690_CR26","doi-asserted-by":"publisher","first-page":"25161","DOI":"10.18632\/oncotarget.4629","volume":"6","author":"MK Jolly","year":"2015","unstructured":"Jolly MK, Jia D, Boareto M, Mani SA, Pienta KJ, Ben-Jacob E, et al. Coupling the modules of EMT and stemness: a tunable stemness window model. Oncotarget. 2015;6:25161\u201374. https:\/\/doi.org\/10.18632\/oncotarget.4629.","journal-title":"Oncotarget"},{"key":"2690_CR27","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1101\/gad.277681.116","volume":"30","author":"T Celi\u00e0-Terrassa","year":"2016","unstructured":"Celi\u00e0-Terrassa T, Kang Y. Distinctive properties of metastasis-initiating cells. Genes Dev. 2016;30:892\u2013908. https:\/\/doi.org\/10.1101\/gad.277681.116.","journal-title":"Genes Dev"},{"key":"2690_CR28","doi-asserted-by":"publisher","unstructured":"Nieto MA, Huang RY-J, Jackson RA, Thiery JPEMT. 2016. Cell. 2016;166:21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028","DOI":"10.1016\/j.cell.2016.06.028"},{"key":"2690_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14:611\u201329. https:\/\/doi.org\/10.1038\/nrclinonc.2017.44.","journal-title":"Nat Rev Clin Oncol"},{"key":"2690_CR30","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23:1124\u201334. https:\/\/doi.org\/10.1038\/nm.4409.","journal-title":"Nat Med"},{"key":"2690_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/cells9030623","volume":"9","author":"T-T Liao","year":"2020","unstructured":"Liao T-T, Yang M-H. Hybrid epithelial\/mesenchymal state in cancer metastasis: clinical significance and regulatory mechanisms. Cells. 2020;9:623. https:\/\/doi.org\/10.3390\/cells9030623.","journal-title":"Cells"},{"key":"2690_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396. https:\/\/doi.org\/10.1038\/nrm3758.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2690_CR33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.bbrc.2015.02.012","volume":"458","author":"M Ozawa","year":"2015","unstructured":"Ozawa M, Kobayashi W. Reversibility of the Snail-induced epithelial-mesenchymal transition revealed by the Cre-loxP system. Biochem Biophys Res Commun. 2015;458:608\u201313. https:\/\/doi.org\/10.1016\/j.bbrc.2015.02.012.","journal-title":"Biochem Biophys Res Commun"},{"key":"2690_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12967-025-06422-5","volume":"23","author":"Y Xie","year":"2025","unstructured":"Xie Y, Wang X, Wang W, Pu N, Liu L. Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges. J Transl Med. 2025;23:386. https:\/\/doi.org\/10.1186\/s12967-025-06422-5.","journal-title":"J Transl Med"},{"key":"2690_CR35","doi-asserted-by":"publisher","first-page":"102113","DOI":"10.1016\/j.isci.2021.102113","volume":"24","author":"V Aggarwal","year":"2021","unstructured":"Aggarwal V, Montoya CA, Donnenberg VS, Sant S. Interplay between tumor microenvironment and partial EMT as the driver of tumor progression. iScience. 2021;24:102113. https:\/\/doi.org\/10.1016\/j.isci.2021.102113.","journal-title":"iScience"},{"key":"2690_CR36","doi-asserted-by":"publisher","first-page":"e108647","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021;40:e108647. https:\/\/doi.org\/10.15252\/embj.2021108647.","journal-title":"EMBO J"},{"key":"2690_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-023-01793-z","volume":"22","author":"A Akhmetkaliyev","year":"2023","unstructured":"Akhmetkaliyev A, Alibrahim N, Shafiee D, Tulchinsky E. EMT\/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin? Mol Cancer. 2023;22:90. https:\/\/doi.org\/10.1186\/s12943-023-01793-z.","journal-title":"Mol Cancer"},{"key":"2690_CR38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello NM, Maddipati R, Norgard RJ, Balli D, Li J, Yuan S, et al. EMT subtype influences epithelial plasticity and mode of cell migration. Dev Cell. 2018;45:681\u2013e6954. https:\/\/doi.org\/10.1016\/j.devcel.2018.05.027.","journal-title":"Dev Cell"},{"key":"2690_CR39","doi-asserted-by":"publisher","first-page":"807324","DOI":"10.3389\/fmolb.2022.807324","volume":"9","author":"SA Vilchez Mercedes","year":"2022","unstructured":"Vilchez Mercedes SA, Bocci F, Ahmed M, Eder I, Zhu N, Levine H, et al. Nrf2 Modulates the hybrid epithelial\/mesenchymal phenotype and notch signaling during collective cancer migration. Front Mol Biosci. 2022;9:807324. https:\/\/doi.org\/10.3389\/fmolb.2022.807324.","journal-title":"Front Mol Biosci"},{"key":"2690_CR40","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1016\/j.devcel.2021.11.006","volume":"56","author":"F L\u00fc\u00f6nd","year":"2021","unstructured":"L\u00fc\u00f6nd F, Sugiyama N, Bill R, Bornes L, Hager C, Tang F, et al. Distinct contributions of partial and full EMT to breast cancer malignancy. Dev Cell. 2021;56:3203\u2013e322111. https:\/\/doi.org\/10.1016\/j.devcel.2021.11.006.","journal-title":"Dev Cell"},{"key":"2690_CR41","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1158\/1541-7786.MCR-20-0067","volume":"18","author":"AJ Gooding","year":"2020","unstructured":"Gooding AJ, Schiemann WP. Epithelial-mesenchymal transition programs and cancer stem cell phenotypes: mediators of breast cancer therapy resistance. Mol Cancer Res. 2020;18:1257\u201370. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0067.","journal-title":"Mol Cancer Res"},{"key":"2690_CR42","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.15252\/emmm.201404208","volume":"6","author":"TZ Tan","year":"2014","unstructured":"Tan TZ, Miow QH, Miki Y, Noda T, Mori S, Huang RY-J, et al. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med. 2014;6:1279\u201393. https:\/\/doi.org\/10.15252\/emmm.201404208.","journal-title":"EMBO Mol Med"},{"key":"2690_CR43","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.trecan.2020.03.011","volume":"6","author":"MM Wilson","year":"2020","unstructured":"Wilson MM, Weinberg RA, Lees JA, Guen VJ. Emerging mechanisms by which EMT programs control stemness. Trends Cancer. 2020;6:775\u201380. https:\/\/doi.org\/10.1016\/j.trecan.2020.03.011.","journal-title":"Trends Cancer"},{"key":"2690_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pharmthera.2018.09.007","volume":"194","author":"MK Jolly","year":"2019","unstructured":"Jolly MK, Somarelli JA, Sheth M, Biddle A, Tripathi SC, Armstrong AJ, et al. Hybrid epithelial\/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas. Pharmacol Ther. 2019;194:161\u201384. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.09.007.","journal-title":"Pharmacol Ther"},{"key":"2690_CR45","doi-asserted-by":"publisher","first-page":"e007895","DOI":"10.1136\/jitc-2023-007895","volume":"12","author":"M Parodi","year":"2024","unstructured":"Parodi M, Centonze G, Murianni F, Orecchia P, Andriani F, Roato I, et al. Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells. J Immunother Cancer. 2024;12:e007895. https:\/\/doi.org\/10.1136\/jitc-2023-007895.","journal-title":"J Immunother Cancer"},{"key":"2690_CR46","doi-asserted-by":"publisher","first-page":"797261","DOI":"10.3389\/fimmu.2021.797261","volume":"12","author":"S Sahoo","year":"2021","unstructured":"Sahoo S, Nayak SP, Hari K, Purkait P, Mandal S, Kishore A, et al. Immunosuppressive traits of the hybrid epithelial\/mesenchymal phenotype. Front Immunol. 2021;12:797261. https:\/\/doi.org\/10.3389\/fimmu.2021.797261.","journal-title":"Front Immunol"},{"key":"2690_CR47","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/bjc.2011.405","volume":"105","author":"A Lecharpentier","year":"2011","unstructured":"Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, Farace F. Detection of circulating tumour cells with a hybrid (epithelial\/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer. 2011;105:1338\u201341. https:\/\/doi.org\/10.1038\/bjc.2011.405.","journal-title":"Br J Cancer"},{"key":"2690_CR48","doi-asserted-by":"publisher","first-page":"1024783","DOI":"10.3389\/fonc.2022.1024783","volume":"12","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Li B, Gao Q, Luo Y, Ming L. Prognostic value of epithelial-mesenchymal transition circulating tumor cells in female breast cancer: a meta-analysis. Front Oncol. 2022;12:1024783. https:\/\/doi.org\/10.3389\/fonc.2022.1024783.","journal-title":"Front Oncol"},{"key":"2690_CR49","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1158\/0008-5472.CAN-17-2459","volume":"78","author":"L-N Qi","year":"2018","unstructured":"Qi L-N, Xiang B-D, Wu F-X, Ye J-Z, Zhong J-H, Wang Y-Y, et al. Circulating tumor cells undergoing emt provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma. Cancer Res. 2018;78:4731\u201344. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2459.","journal-title":"Cancer Res"},{"key":"2690_CR50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41568-019-0213-x","volume":"19","author":"ED Williams","year":"2019","unstructured":"Williams ED, Gao D, Redfern A, Thompson EW. Controversies around epithelial-mesenchymal plasticity in cancer metastasis. Nat Rev Cancer. 2019;19:716\u201332. https:\/\/doi.org\/10.1038\/s41568-019-0213-x.","journal-title":"Nat Rev Cancer"},{"key":"2690_CR51","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1158\/0008-5472.CAN-16-3521","volume":"77","author":"JT George","year":"2017","unstructured":"George JT, Jolly MK, Xu S, Somarelli JA, Levine H. Survival outcomes in cancer patients predicted by a partial emt gene expression scoring metric. Cancer Res. 2017;77:6415\u201328. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3521.","journal-title":"Cancer Res"},{"key":"2690_CR52","doi-asserted-by":"publisher","first-page":"39401","DOI":"10.18632\/oncotarget.17031","volume":"8","author":"R-S Wu","year":"2017","unstructured":"Wu R-S, Hong J-J, Wu J-F, Yan S, Wu D, Liu N, et al. OVOL2 antagonizes TGF-\u03b2 signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis. Oncotarget. 2017;8:39401\u201316. https:\/\/doi.org\/10.18632\/oncotarget.17031.","journal-title":"Oncotarget"},{"key":"2690_CR53","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3892\/ol.2018.9741","volume":"17","author":"G Wang","year":"2019","unstructured":"Wang G, Pan J, Zhang L, Wang C. Overexpression of grainyhead-like transcription factor 2 is associated with poor prognosis in human pancreatic carcinoma. Oncol Lett. 2019;17:1491\u20136. https:\/\/doi.org\/10.3892\/ol.2018.9741.","journal-title":"Oncol Lett"},{"key":"2690_CR54","doi-asserted-by":"publisher","first-page":"27067","DOI":"10.18632\/oncotarget.8166","volume":"7","author":"MK Jolly","year":"2016","unstructured":"Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, et al. Stability of the hybrid epithelial\/mesenchymal phenotype. Oncotarget. 2016;7:27067\u201384. https:\/\/doi.org\/10.18632\/oncotarget.8166.","journal-title":"Oncotarget"},{"key":"2690_CR55","doi-asserted-by":"publisher","first-page":"15436","DOI":"10.18632\/oncotarget.3623","volume":"6","author":"D Jia","year":"2015","unstructured":"Jia D, Jolly MK, Boareto M, Parsana P, Mooney SM, Pienta KJ, et al. OVOL guides the epithelial-hybrid-mesenchymal transition. Oncotarget. 2015;6:15436\u201348. https:\/\/doi.org\/10.18632\/oncotarget.3623.","journal-title":"Oncotarget"},{"key":"2690_CR56","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature15748","volume":"527","author":"KR Fischer","year":"2015","unstructured":"Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong STC, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015;527:472\u20136. https:\/\/doi.org\/10.1038\/nature15748.","journal-title":"Nature"},{"key":"2690_CR57","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349\u201361. https:\/\/doi.org\/10.1016\/j.cell.2011.11.025.","journal-title":"Cell"},{"key":"2690_CR58","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature16064","volume":"527","author":"X Zheng","year":"2015","unstructured":"Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature. 2015;527:525\u201330. https:\/\/doi.org\/10.1038\/nature16064.","journal-title":"Nature"},{"key":"2690_CR59","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1038\/nature22817","volume":"547","author":"KR Fischer","year":"2017","unstructured":"Fischer KR, Altorki NK, Mittal V, Gao D, Fischer, et al. reply Nat. 2017;547:E5\u20136. https:\/\/doi.org\/10.1038\/nature22817.","journal-title":"reply Nat"},{"key":"2690_CR60","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","volume":"35","author":"CL Chaffer","year":"2016","unstructured":"Chaffer CL, San Juan BP, Lim E, Weinberg RA. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35:645\u201354. https:\/\/doi.org\/10.1007\/s10555-016-9648-7.","journal-title":"Cancer Metastasis Rev"},{"key":"2690_CR61","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147:275\u201392. https:\/\/doi.org\/10.1016\/j.cell.2011.09.024.","journal-title":"Cell"},{"key":"2690_CR62","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1038\/s41467-021-25333-9","volume":"12","author":"S Di Franco","year":"2021","unstructured":"Di Franco S, Bianca P, Sardina DS, Turdo A, Gaggianesi M, Veschi V, et al. Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery. Nat Commun. 2021;12:5006. https:\/\/doi.org\/10.1038\/s41467-021-25333-9.","journal-title":"Nat Commun"},{"key":"2690_CR63","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704\u201315. https:\/\/doi.org\/10.1016\/j.cell.2008.03.027.","journal-title":"Cell"},{"key":"2690_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s43856-024-00512-z","volume":"4","author":"AP van der Zalm","year":"2024","unstructured":"van der Zalm AP, Dings MPG, Manoukian P, Boersma H, Janssen R, Bailey P, et al. The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma. Commun Med (Lond). 2024;4:89. https:\/\/doi.org\/10.1038\/s43856-024-00512-z.","journal-title":"Commun Med (Lond)"},{"key":"2690_CR65","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1159\/000512520","volume":"211","author":"AR Subbalakshmi","year":"2022","unstructured":"Subbalakshmi AR, Sahoo S, Biswas K, Jolly MK. A computational systems biology approach identifies SLUG as a mediator of partial epithelial-mesenchymal transition (EMT). Cells Tissues Organs. 2022;211:689\u2013702. https:\/\/doi.org\/10.1159\/000512520.","journal-title":"Cells Tissues Organs"},{"key":"2690_CR66","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s12672-025-02866-9","volume":"16","author":"F Lu","year":"2025","unstructured":"Lu F, Li L, Wang L, Shu S, Gao J, Chang L, et al. Integrative stemness- and EMT-related gene signatures associated with prognosis and the immune microenvironment in lung adenocarcinoma. Discov Oncol. 2025;16:1139. https:\/\/doi.org\/10.1007\/s12672-025-02866-9.","journal-title":"Discov Oncol"},{"key":"2690_CR67","doi-asserted-by":"publisher","first-page":"1417201","DOI":"10.3389\/fimmu.2024.1417201","volume":"15","author":"Z-N Lei","year":"2024","unstructured":"Lei Z-N, Teng Q-X, Koya J, Liu Y, Chen Z, Zeng L, et al. The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis. Front Immunol. 2024;15:1417201. https:\/\/doi.org\/10.3389\/fimmu.2024.1417201.","journal-title":"Front Immunol"},{"key":"2690_CR68","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-023-04120-8","volume":"21","author":"Z Li","year":"2023","unstructured":"Li Z, Yang Z, Liu W, Zhu W, Yin L, Han Z, et al. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt\/\u03b2-catenin\/c-Myc\/SOX2 pathway in colorectal cancer. J Transl Med. 2023;21:302. https:\/\/doi.org\/10.1186\/s12967-023-04120-8.","journal-title":"J Transl Med"},{"key":"2690_CR69","doi-asserted-by":"publisher","first-page":"116909","DOI":"10.1016\/j.celrep.2025.116909","volume":"45","author":"L Lan","year":"2026","unstructured":"Lan L, Li H, Zhang S, Garrone CM, Wu Y, Zaw Thin M, et al. A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cells. Cell Rep. 2026;45:116909. https:\/\/doi.org\/10.1016\/j.celrep.2025.116909.","journal-title":"Cell Rep"},{"key":"2690_CR70","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41576-023-00601-0","volume":"24","author":"J Haerinck","year":"2023","unstructured":"Haerinck J, Goossens S, Berx G. The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation. Nat Rev Genet. 2023;24:590\u2013609. https:\/\/doi.org\/10.1038\/s41576-023-00601-0.","journal-title":"Nat Rev Genet"},{"key":"2690_CR71","doi-asserted-by":"publisher","unstructured":"Lee E, Wang J, Yumoto K, Jung Y, Cackowski FC, Decker AM et al. DNMT1 regulates epithelial-mesenchymal transition and cancer stem cells, which promotes prostate cancer metastasis. Neoplasia. New York, N.Y.; 2016;18:553\u201366. https:\/\/doi.org\/10.1016\/j.neo.2016.07.007","DOI":"10.1016\/j.neo.2016.07.007"},{"key":"2690_CR72","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccr.2013.08.005","volume":"24","author":"WL Tam","year":"2013","unstructured":"Tam WL, Lu H, Buikhuisen J, Soh BS, Lim E, Reinhardt F, et al. Protein kinase C \u03b1 is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell. 2013;24:347\u201364. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.005.","journal-title":"Cancer Cell"},{"key":"2690_CR73","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/cells14030227","volume":"14","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Tang Y, Fang Z, Wen J, Wicha MS, Luo M. Long Non-Coding RNAs: Key regulators of tumor epithelial\/mesenchymal plasticity and cancer stemness. Cells. 2025;14:227. https:\/\/doi.org\/10.3390\/cells14030227.","journal-title":"Cells"},{"key":"2690_CR74","first-page":"1099","volume":"6","author":"J Li","year":"2016","unstructured":"Li J, Wang J, Chen Y, Li S, Jin M, Wang H, et al. LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204. Am J Cancer Res. 2016;6:1099\u2013107.","journal-title":"Am J Cancer Res"},{"key":"2690_CR75","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1039\/c5mb00685f","volume":"12","author":"R Sun","year":"2016","unstructured":"Sun R, Qin C, Jiang B, Fang S, Pan X, Peng L, et al. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition. Mol Biosyst. 2016;12:952\u201362. https:\/\/doi.org\/10.1039\/c5mb00685f.","journal-title":"Mol Biosyst"},{"key":"2690_CR76","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13046-023-02725-x","volume":"42","author":"L Amicone","year":"2023","unstructured":"Amicone L, Marchetti A, Cicchini C. The lncRNA HOTAIR: a pleiotropic regulator of epithelial cell plasticity. J Exp Clin Cancer Res. 2023;42:147. https:\/\/doi.org\/10.1186\/s13046-023-02725-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"2690_CR77","doi-asserted-by":"publisher","unstructured":"Wei X, Ge Y, Zheng Y, Zhao S, Zhou Y, Chang Y et al. Hybrid EMT phenotype and cell membrane tension promote colorectal cancer resistance to ferroptosis. Adv Sci (Weinh). Weinheim, Baden-Wurttemberg, Germany; 2025;12:e2413882. https:\/\/doi.org\/10.1002\/advs.202413882","DOI":"10.1002\/advs.202413882"},{"key":"2690_CR78","doi-asserted-by":"publisher","unstructured":"Chen L, Boleslaw Olszewski M, Kruithof-de Julio M, Snaar-Jagalska BE. Zebrafish microenvironment elevates EMT and CSC-like phenotype of engrafted prostate cancer cells. Cells. 2020;9:797. https:\/\/doi.org\/10.3390\/cells9040797.","DOI":"10.3390\/cells9040797"},{"key":"2690_CR79","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12964-022-00888-2","volume":"20","author":"X Chen","year":"2022","unstructured":"Chen X, Yang M, Yin J, Li P, Zeng S, Zheng G, et al. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2\/AKT\/\u03b2-catenin signaling. Cell Commun Signal. 2022;20:92. https:\/\/doi.org\/10.1186\/s12964-022-00888-2.","journal-title":"Cell Commun Signal"},{"key":"2690_CR80","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12967-025-06292-x","volume":"23","author":"C-C Ko","year":"2025","unstructured":"Ko C-C, Yang P-M. Hypoxia-induced MIR31HG expression promotes partial EMT and basal-like phenotype in pancreatic ductal adenocarcinoma based on data mining and experimental analyses. J Transl Med. 2025;23:305. https:\/\/doi.org\/10.1186\/s12967-025-06292-x.","journal-title":"J Transl Med"},{"key":"2690_CR81","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/sj.bjc.6605369","volume":"101","author":"K Lundgren","year":"2009","unstructured":"Lundgren K, Nordenskj\u00f6ld B, Landberg G, Hypoxia. Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer. 2009;101:1769\u201381. https:\/\/doi.org\/10.1038\/sj.bjc.6605369.","journal-title":"Br J Cancer"},{"key":"2690_CR82","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-03046-1","volume":"589","author":"I Pastushenko","year":"2021","unstructured":"Pastushenko I, Mauri F, Song Y, de Cock F, Meeusen B, Swedlund B, et al. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis. Nature. 2021;589:448\u201355. https:\/\/doi.org\/10.1038\/s41586-020-03046-1.","journal-title":"Nature"},{"key":"2690_CR83","doi-asserted-by":"publisher","first-page":"E2337","DOI":"10.1073\/pnas.1618298114","volume":"114","author":"B Bierie","year":"2017","unstructured":"Bierie B, Pierce SE, Kroeger C, Stover DG, Pattabiraman DR, Thiru P, et al. Integrin-\u03b24 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc Natl Acad Sci U S A. 2017;114:E2337\u201346. https:\/\/doi.org\/10.1073\/pnas.1618298114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2690_CR84","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1073\/pnas.1812876116","volume":"116","author":"C Kr\u00f6ger","year":"2019","unstructured":"Kr\u00f6ger C, Afeyan A, Mraz J, Eaton EN, Reinhardt F, Khodor YL, et al. Acquisition of a hybrid E\/M state is essential for tumorigenicity of basal breast cancer cells. Proc Natl Acad Sci U S A. 2019;116:7353\u201362. https:\/\/doi.org\/10.1073\/pnas.1812876116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2690_CR85","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1073\/pnas.1907473116","volume":"116","author":"Correction for Kr\u00f6ger","year":"2019","unstructured":"Correction for Kr\u00f6ger. Acquisition of a hybrid E\/M state is essential for tumorigenicity of basal breast cancer cells. Proc Natl Acad Sci U S A. 2019;116:11553\u20134. https:\/\/doi.org\/10.1073\/pnas.1907473116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2690_CR86","doi-asserted-by":"publisher","first-page":"10554","DOI":"10.3390\/ijms251910554","volume":"25","author":"BR Doran","year":"2024","unstructured":"Doran BR, Moffitt LR, Wilson AL, Stephens AN, Bilandzic M. Leader cells: invade and evade-the frontline of cancer progression. Int J Mol Sci. 2024;25:10554. https:\/\/doi.org\/10.3390\/ijms251910554.","journal-title":"Int J Mol Sci"},{"key":"2690_CR87","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10585-018-9906-x","volume":"35","author":"AD Redfern","year":"2018","unstructured":"Redfern AD, Spalding LJ, Thompson EW. The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome. Clin Exp Metastasis. 2018;35:285\u2013308. https:\/\/doi.org\/10.1007\/s10585-018-9906-x.","journal-title":"Clin Exp Metastasis"},{"key":"2690_CR88","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu W, Kang Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev Cell. 2019;49:361\u201374. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.010.","journal-title":"Dev Cell"},{"key":"2690_CR89","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s43018-024-00839-5","volume":"5","author":"KK Youssef","year":"2024","unstructured":"Youssef KK, Narwade N, Arcas A, Marquez-Galera A, Jim\u00e9nez-Casta\u00f1o R, Lopez-Blau C, et al. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations. Nat Cancer. 2024;5:1660\u201380. https:\/\/doi.org\/10.1038\/s43018-024-00839-5.","journal-title":"Nat Cancer"},{"key":"2690_CR90","doi-asserted-by":"publisher","first-page":"113470","DOI":"10.1016\/j.celrep.2023.113470","volume":"42","author":"NA Kuburich","year":"2023","unstructured":"Kuburich NA, den Hollander P, Castaneda M, Pietil\u00e4 M, Tang X, Batra H, et al. Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial\/mesenchymal carcinomas. Cell Rep. 2023;42:113470. https:\/\/doi.org\/10.1016\/j.celrep.2023.113470.","journal-title":"Cell Rep"},{"key":"2690_CR91","doi-asserted-by":"publisher","first-page":"115064","DOI":"10.1016\/j.celrep.2024.115064","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao Y, Xia Z, Xia W, Jiang P. Metabolic reprogramming, sensing, and cancer therapy. Cell Rep. 2024;43:115064. https:\/\/doi.org\/10.1016\/j.celrep.2024.115064.","journal-title":"Cell Rep"},{"key":"2690_CR92","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12964-024-01957-4","volume":"22","author":"M Liaghat","year":"2024","unstructured":"Liaghat M, Ferdousmakan S, Mortazavi SH, Yahyazadeh S, Irani A, Banihashemi S, et al. The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors. Cell Commun Signal. 2024;22:575. https:\/\/doi.org\/10.1186\/s12964-024-01957-4.","journal-title":"Cell Commun Signal"},{"key":"2690_CR93","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.3390\/cancers14215345","volume":"14","author":"Y Xie","year":"2022","unstructured":"Xie Y, Ma S, Tong M. Metabolic plasticity of cancer stem cells in response to microenvironmental cues. Cancers (Basel). 2022;14:5345. https:\/\/doi.org\/10.3390\/cancers14215345.","journal-title":"Cancers (Basel)"},{"key":"2690_CR94","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan Y, Li J, Zhao G, Huang K-C, Cardenas H, Wang Y, et al. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat Commun. 2022;13:4554. https:\/\/doi.org\/10.1038\/s41467-022-32101-w.","journal-title":"Nat Commun"},{"key":"2690_CR95","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y, et al. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer. 2024;23:261. https:\/\/doi.org\/10.1186\/s12943-024-02165-x.","journal-title":"Mol Cancer"},{"key":"2690_CR96","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41416-021-01385-y","volume":"124","author":"D Jia","year":"2021","unstructured":"Jia D, Park JH, Kaur H, Jung KH, Yang S, Tripathi S, et al. Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer. Br J Cancer. 2021;124:1902\u201311. https:\/\/doi.org\/10.1038\/s41416-021-01385-y.","journal-title":"Br J Cancer"},{"key":"2690_CR97","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2003.11.136","volume":"313","author":"XL Zu","year":"2004","unstructured":"Zu XL, Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun. 2004;313:459\u201365. https:\/\/doi.org\/10.1016\/j.bbrc.2003.11.136.","journal-title":"Biochem Biophys Res Commun"},{"key":"2690_CR98","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.pan.2020.04.014","volume":"20","author":"SA Krapf","year":"2020","unstructured":"Krapf SA, Lund J, Lundkvist M, Dale MG, Nyman TA, Thoresen GH, et al. Pancreatic cancer cells show lower oleic acid oxidation and their conditioned medium inhibits oleic acid oxidation in human myotubes. Pancreatology. 2020;20:676\u201382. https:\/\/doi.org\/10.1016\/j.pan.2020.04.014.","journal-title":"Pancreatology"},{"key":"2690_CR99","doi-asserted-by":"publisher","first-page":"105719","DOI":"10.1016\/j.isci.2022.105719","volume":"26","author":"M Galbraith","year":"2023","unstructured":"Galbraith M, Levine H, Onuchic JN, Jia D. Decoding the coupled decision-making of the epithelial-mesenchymal transition and metabolic reprogramming in cancer. iScience. 2023;26:105719. https:\/\/doi.org\/10.1016\/j.isci.2022.105719.","journal-title":"iScience"},{"key":"2690_CR100","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1073\/pnas.1816391116","volume":"116","author":"D Jia","year":"2019","unstructured":"Jia D, Lu M, Jung KH, Park JH, Yu L, Onuchic JN, et al. Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways. Proc Natl Acad Sci USA. 2019;116:3909\u201318. https:\/\/doi.org\/10.1073\/pnas.1816391116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2690_CR101","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-16-2074","volume":"77","author":"L Yu","year":"2017","unstructured":"Yu L, Lu M, Jia D, Ma J, Ben-Jacob E, Levine H, et al. Modeling the genetic regulation of cancer metabolism: interplay between glycolysis and oxidative phosphorylation. Cancer Res. 2017;77:1564\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2074.","journal-title":"Cancer Res"},{"key":"2690_CR102","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cmet.2018.06.006","volume":"28","author":"M Luo","year":"2018","unstructured":"Luo M, Shang L, Brooks MD, Jiagge E, Zhu Y, Buschhaus JM, et al. Targeting breast cancer stem cell state equilibrium through modulation of redox signaling. Cell Metab. 2018;28:69\u2013e866. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.006.","journal-title":"Cell Metab"},{"key":"2690_CR103","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.stemcr.2018.03.001","volume":"10","author":"JA Colacino","year":"2018","unstructured":"Colacino JA, Azizi E, Brooks MD, Harouaka R, Fouladdel S, McDermott SP, et al. Heterogeneity of human breast stem and progenitor cells as revealed by transcriptional profiling. Stem Cell Rep. 2018;10:1596\u2013609. https:\/\/doi.org\/10.1016\/j.stemcr.2018.03.001.","journal-title":"Stem Cell Rep"},{"key":"2690_CR104","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41416-023-02522-5","volume":"130","author":"Z Ren","year":"2024","unstructured":"Ren Z, Dharmaratne M, Liang H, Benard O, Morales-Gallego M, Suyama K, et al. Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1\u03b1. Br J Cancer. 2024;130:908\u201324. https:\/\/doi.org\/10.1038\/s41416-023-02522-5.","journal-title":"Br J Cancer"},{"key":"2690_CR105","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ncb3039","volume":"16","author":"VS LeBleu","year":"2014","unstructured":"LeBleu VS, O\u2019Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, et al. PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol. 2014;16:992\u20131003. https:\/\/doi.org\/10.1038\/ncb3039.","journal-title":"Nat Cell Biol"},{"key":"2690_CR106","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1038\/s41388-024-03156-4","volume":"43","author":"W Fernando","year":"2024","unstructured":"Fernando W, Cruickshank BM, Arun RP, MacLean MR, Cahill HF, Morales-Quintanilla F, et al. ALDH1A3 is the switch that determines the balance of ALDH\u2009+\u2009and CD24-CD44\u2009+\u2009cancer stem cells, EMT-MET, and glucose metabolism in breast cancer. Oncogene. 2024;43:3151\u201369. https:\/\/doi.org\/10.1038\/s41388-024-03156-4.","journal-title":"Oncogene"},{"key":"2690_CR107","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000004094","author":"K Sun","year":"2025","unstructured":"Sun K, Ling H, Peng F, Yang T, Hao Y, Bai Q, et al. FADS3 fuels CcRCC progression via lipid-droplet\/TGF-\u03b2 receptors axis bridging metabolic reprogramming and epithelial plasticity. Int J Surg. 2025. https:\/\/doi.org\/10.1097\/JS9.0000000000004094. cited 2026 Jan 28.","journal-title":"Int J Surg [Internet]"},{"key":"2690_CR108","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fonc.2019.01446","volume":"9","author":"H Cai","year":"2019","unstructured":"Cai H, Li J, Zhang Y, Liao Y, Zhu Y, Wang C, et al. LDHA Promotes oral squamous cell carcinoma progression through facilitating glycolysis and epithelial-mesenchymal transition. Front Oncol. 2019;9:1446. https:\/\/doi.org\/10.3389\/fonc.2019.01446.","journal-title":"Front Oncol"},{"key":"2690_CR109","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41467-019-14262-3","volume":"11","author":"C Corbet","year":"2020","unstructured":"Corbet C, Bastien E, Santiago de Jesus JP, Dierge E, Martherus R, Vander Linden C, et al. TGF\u03b22-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells. Nat Commun. 2020;11:454. https:\/\/doi.org\/10.1038\/s41467-019-14262-3.","journal-title":"Nat Commun"},{"key":"2690_CR110","doi-asserted-by":"publisher","first-page":"747001","DOI":"10.3389\/fphar.2021.747001","volume":"12","author":"MA Khajah","year":"2021","unstructured":"Khajah MA, Khushaish S, Luqmani YA. Lactate dehydrogenase a or b knockdown reduces lactate production and inhibits breast cancer cell motility in vitro. Front Pharmacol. 2021;12:747001. https:\/\/doi.org\/10.3389\/fphar.2021.747001.","journal-title":"Front Pharmacol"},{"key":"2690_CR111","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccr.2008.03.015","volume":"13","author":"Z Weihua","year":"2008","unstructured":"Weihua Z, Tsan R, Huang W-C, Wu Q, Chiu C-H, Fidler IJ, et al. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell. 2008;13:385\u201393. https:\/\/doi.org\/10.1016\/j.ccr.2008.03.015.","journal-title":"Cancer Cell"},{"key":"2690_CR112","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1038\/emm.2016.81","volume":"48","author":"S-M Jeon","year":"2016","unstructured":"Jeon S-M. Regulation and function of AMPK in physiology and diseases. Exp Mol Med. 2016;48:e245. https:\/\/doi.org\/10.1038\/emm.2016.81.","journal-title":"Exp Mol Med"},{"key":"2690_CR113","doi-asserted-by":"publisher","first-page":"120111","DOI":"10.1016\/j.lfs.2021.120111","volume":"291","author":"AV Ulasov","year":"2022","unstructured":"Ulasov AV, Rosenkranz AA, Georgiev GP, Sobolev AS. Nrf2\/Keap1\/ARE signaling: towards specific regulation. Life Sci. 2022;291:120111. https:\/\/doi.org\/10.1016\/j.lfs.2021.120111.","journal-title":"Life Sci"},{"key":"2690_CR114","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.3390\/ijms22094376","volume":"22","author":"M-Y Song","year":"2021","unstructured":"Song M-Y, Lee D-Y, Chun K-S, Kim E-H. The Role of NRF2\/KEAP1 signaling pathway in cancer metabolism. Int J Mol Sci. 2021;22:4376. https:\/\/doi.org\/10.3390\/ijms22094376.","journal-title":"Int J Mol Sci"},{"key":"2690_CR115","doi-asserted-by":"publisher","first-page":"66360","DOI":"10.18632\/oncotarget.11960","volume":"7","author":"I Riz","year":"2016","unstructured":"Riz I, Hawley TS, Marsal JW, Hawley RG. Noncanonical SQSTM1\/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming. Oncotarget. 2016;7:66360\u201385. https:\/\/doi.org\/10.18632\/oncotarget.11960.","journal-title":"Oncotarget"},{"key":"2690_CR116","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1089\/ars.2010.3834","volume":"15","author":"HY Kay","year":"2011","unstructured":"Kay HY, Kim WD, Hwang SJ, Choi H-S, Gilroy RK, Wan Y-JY, et al. Nrf2 inhibits LXR\u03b1-dependent hepatic lipogenesis by competing with FXR for acetylase binding. Antioxid Redox Signal. 2011;15:2135\u201346. https:\/\/doi.org\/10.1089\/ars.2010.3834.","journal-title":"Antioxid Redox Signal"},{"key":"2690_CR117","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.abb.2015.11.040","volume":"591","author":"SL Slocum","year":"2016","unstructured":"Slocum SL, Skoko JJ, Wakabayashi N, Aja S, Yamamoto M, Kensler TW, et al. Keap1\/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet. Arch Biochem Biophys. 2016;591:57\u201365. https:\/\/doi.org\/10.1016\/j.abb.2015.11.040.","journal-title":"Arch Biochem Biophys"},{"key":"2690_CR118","doi-asserted-by":"publisher","first-page":"RP104374","DOI":"10.7554\/eLife.104374","volume":"13","author":"A Matsumoto","year":"2026","unstructured":"Matsumoto A, Inoko A, Tanaka T, Konishi G-I, Hosoda W, Kojima T, et al. Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balance. eLife. 2026;13:RP104374. https:\/\/doi.org\/10.7554\/eLife.104374.","journal-title":"eLife"},{"key":"2690_CR119","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3390\/cancers13081973","volume":"13","author":"Y Daniel","year":"2021","unstructured":"Daniel Y, Lelou E, Aninat C, Corlu A, Cabillic F. Interplay between metabolism reprogramming and epithelial-to-mesenchymal transition in cancer stem cells. Cancers (Basel). 2021;13:1973. https:\/\/doi.org\/10.3390\/cancers13081973.","journal-title":"Cancers (Basel)"},{"key":"2690_CR120","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","volume":"279","author":"CR Santos","year":"2012","unstructured":"Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012;279:2610\u201323. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08644.x.","journal-title":"FEBS J"},{"key":"2690_CR121","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s13046-019-1391-9","volume":"38","author":"J Wen","year":"2019","unstructured":"Wen J, Min X, Shen M, Hua Q, Han Y, Zhao L, et al. ACLY facilitates colon cancer cell metastasis by CTNNB1. J Exp Clin Cancer Res. 2019;38:401. https:\/\/doi.org\/10.1186\/s13046-019-1391-9.","journal-title":"J Exp Clin Cancer Res"},{"key":"2690_CR122","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-08-1235","volume":"68","author":"T Migita","year":"2008","unstructured":"Migita T, Narita T, Nomura K, Miyagi E, Inazuka F, Matsuura M, et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res. 2008;68:8547\u201354. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1235.","journal-title":"Cancer Res"},{"key":"2690_CR123","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/jcp.22895","volume":"227","author":"J Hanai","year":"2012","unstructured":"Hanai J, Doro N, Sasaki AT, Kobayashi S, Cantley LC, Seth P, et al. Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)\/AKT pathways. J Cell Physiol. 2012;227:1709\u201320. https:\/\/doi.org\/10.1002\/jcp.22895.","journal-title":"J Cell Physiol"},{"key":"2690_CR124","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/cancers13040762","volume":"13","author":"O Shuvalov","year":"2021","unstructured":"Shuvalov O, Daks A, Fedorova O, Petukhov A, Barlev N. Linking metabolic reprogramming, plasticity and tumor progression. Cancers (Basel). 2021;13:762. https:\/\/doi.org\/10.3390\/cancers13040762.","journal-title":"Cancers (Basel)"},{"key":"2690_CR125","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fcell.2020.00760","volume":"8","author":"X Lai","year":"2020","unstructured":"Lai X, Li Q, Wu F, Lin J, Chen J, Zheng H, et al. Epithelial-mesenchymal transition and metabolic switching in cancer: lessons from somatic cell reprogramming. Front Cell Dev Biol. 2020;8:760. https:\/\/doi.org\/10.3389\/fcell.2020.00760.","journal-title":"Front Cell Dev Biol"},{"key":"2690_CR126","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2016.09.020","volume":"384","author":"J Luo","year":"2017","unstructured":"Luo J, Hong Y, Lu Y, Qiu S, Chaganty BKR, Zhang L, et al. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab. Cancer Lett. 2017;384:39\u201349. https:\/\/doi.org\/10.1016\/j.canlet.2016.09.020.","journal-title":"Cancer Lett"},{"key":"2690_CR127","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.metabol.2014.02.010","volume":"63","author":"Y Xu","year":"2014","unstructured":"Xu Y, Huang J, Xin W, Chen L, Zhao X, Lv Z, et al. Lipid accumulation is ahead of epithelial-to-mesenchymal transition and therapeutic intervention by acetyl-CoA carboxylase 2 silence in diabetic nephropathy. Metabolism. 2014;63:716\u201326. https:\/\/doi.org\/10.1016\/j.metabol.2014.02.010.","journal-title":"Metabolism"},{"key":"2690_CR128","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.cmet.2017.09.018","volume":"26","author":"M Rios Garcia","year":"2017","unstructured":"Rios Garcia M, Steinbauer B, Srivastava K, Singhal M, Mattijssen F, Maida A, et al. Acetyl-CoA Carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence. Cell Metab. 2017;26:842\u2013e8555. https:\/\/doi.org\/10.1016\/j.cmet.2017.09.018.","journal-title":"Cell Metab"},{"key":"2690_CR129","first-page":"69","volume":"1","author":"H Liu","year":"2010","unstructured":"Liu H, Liu J-Y, Wu X, Zhang J-T. Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis\/prognosis marker. Int J Biochem Mol Biol. 2010;1:69\u201389.","journal-title":"Int J Biochem Mol Biol"},{"key":"2690_CR130","doi-asserted-by":"publisher","first-page":"e0147717","DOI":"10.1371\/journal.pone.0147717","volume":"11","author":"Y Yasumoto","year":"2016","unstructured":"Yasumoto Y, Miyazaki H, Vaidyan LK, Kagawa Y, Ebrahimi M, Yamamoto Y, et al. Inhibition of fatty acid synthase decreases expression of stemness markers in glioma stem cells. PLoS ONE. 2016;11:e0147717. https:\/\/doi.org\/10.1371\/journal.pone.0147717.","journal-title":"PLoS ONE"},{"key":"2690_CR131","doi-asserted-by":"publisher","first-page":"55543","DOI":"10.18632\/oncotarget.10837","volume":"7","author":"L Yang","year":"2016","unstructured":"Yang L, Zhang F, Wang X, Tsai Y, Chuang K-H, Keng PC, et al. A FASN-TGF-\u03b21-FASN regulatory loop contributes to high EMT\/metastatic potential of cisplatin-resistant non-small cell lung cancer. Oncotarget. 2016;7:55543\u201354. https:\/\/doi.org\/10.18632\/oncotarget.10837.","journal-title":"Oncotarget"},{"key":"2690_CR132","doi-asserted-by":"publisher","first-page":"17454","DOI":"10.1038\/srep17454","volume":"5","author":"R Singh","year":"2015","unstructured":"Singh R, Yadav V, Kumar S, Saini N. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1. Sci Rep. 2015;5:17454. https:\/\/doi.org\/10.1038\/srep17454.","journal-title":"Sci Rep"},{"key":"2690_CR133","doi-asserted-by":"publisher","first-page":"5934","DOI":"10.3892\/ol.2017.6954","volume":"14","author":"T Chen","year":"2017","unstructured":"Chen T, Zhou L, Li H, Tian Y, Li J, Dong L, et al. Fatty acid synthase affects expression of ErbB receptors in epithelial to mesenchymal transition of breast cancer cells and invasive ductal carcinoma. Oncol Lett. 2017;14:5934\u201346. https:\/\/doi.org\/10.3892\/ol.2017.6954.","journal-title":"Oncol Lett"},{"key":"2690_CR134","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-018-0711-9","volume":"37","author":"H Ran","year":"2018","unstructured":"Ran H, Zhu Y, Deng R, Zhang Q, Liu X, Feng M, et al. Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN. J Exp Clin Cancer Res. 2018;37:54. https:\/\/doi.org\/10.1186\/s13046-018-0711-9.","journal-title":"J Exp Clin Cancer Res"},{"key":"2690_CR135","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cas.12032","volume":"104","author":"D Mauvoisin","year":"2013","unstructured":"Mauvoisin D, Charfi C, Lounis AM, Rassart E, Mounier C. Decreasing stearoyl-CoA desaturase-1 expression inhibits \u03b2-catenin signaling in breast cancer cells. Cancer Sci. 2013;104:36\u201342. https:\/\/doi.org\/10.1111\/cas.12032.","journal-title":"Cancer Sci"},{"key":"2690_CR136","doi-asserted-by":"publisher","first-page":"38719","DOI":"10.18632\/oncotarget.5340","volume":"6","author":"R S\u00e1nchez-Mart\u00ednez","year":"2015","unstructured":"S\u00e1nchez-Mart\u00ednez R, Cruz-Gil S, G\u00f3mez de Cedr\u00f3n M, \u00c1lvarez-Fern\u00e1ndez M, Vargas T, Molina S, et al. A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy. Oncotarget. 2015;6:38719\u201336. https:\/\/doi.org\/10.18632\/oncotarget.5340.","journal-title":"Oncotarget"},{"key":"2690_CR137","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.3390\/ijms20153624","volume":"20","author":"M Rossi Sebastiano","year":"2019","unstructured":"Rossi Sebastiano M, Konstantinidou G. Targeting Long Chain Acyl-CoA synthetases for cancer therapy. Int J Mol Sci. 2019;20:3624. https:\/\/doi.org\/10.3390\/ijms20153624.","journal-title":"Int J Mol Sci"},{"key":"2690_CR138","doi-asserted-by":"publisher","first-page":"11143","DOI":"10.1038\/s41598-017-11612-3","volume":"7","author":"R S\u00e1nchez-Mart\u00ednez","year":"2017","unstructured":"S\u00e1nchez-Mart\u00ednez R, Cruz-Gil S, Garc\u00eda-\u00c1lvarez MS, Reglero G, Ram\u00edrez de Molina A. Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells. Sci Rep. 2017;7:11143. https:\/\/doi.org\/10.1038\/s41598-017-11612-3.","journal-title":"Sci Rep"},{"key":"2690_CR139","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13578-019-0293-z","volume":"9","author":"A Pouyafar","year":"2019","unstructured":"Pouyafar A, Heydarabad MZ, Abdolalizadeh J, Zade JA, Rahbarghazi R, Talebi M. Modulation of lipolysis and glycolysis pathways in cancer stem cells changed multipotentiality and differentiation capacity toward endothelial lineage. Cell Biosci. 2019;9:30. https:\/\/doi.org\/10.1186\/s13578-019-0293-z.","journal-title":"Cell Biosci"},{"key":"2690_CR140","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13578-019-0301-3","volume":"9","author":"A Pouyafar","year":"2019","unstructured":"Pouyafar A, Heydarabad MZ, Abdolalizadeh J, Rahbarghazi R, Talebi M. Correction to: Modulation of lipolysis and glycolysis pathways in cancer stem cells changed multipotentiality and differentiation capacity toward endothelial lineage. Cell Biosci. 2019;9:37. https:\/\/doi.org\/10.1186\/s13578-019-0301-3.","journal-title":"Cell Biosci"},{"key":"2690_CR141","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fonc.2017.00040","volume":"7","author":"A Morandi","year":"2017","unstructured":"Morandi A, Taddei ML, Chiarugi P, Giannoni E. Targeting the metabolic reprogramming that controls epithelial-to-mesenchymal transition in aggressive tumors. Front Oncol. 2017;7:40. https:\/\/doi.org\/10.3389\/fonc.2017.00040.","journal-title":"Front Oncol"},{"key":"2690_CR142","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41420-025-02554-1","volume":"11","author":"Y Lei","year":"2025","unstructured":"Lei Y, Cai S, Zhang J-K, Ding S-Q, Zhang Z-H, Zhang C-D, et al. The role and mechanism of fatty acid oxidation in cancer drug resistance. Cell Death Discov. 2025;11:277. https:\/\/doi.org\/10.1038\/s41420-025-02554-1.","journal-title":"Cell Death Discov"},{"key":"2690_CR143","doi-asserted-by":"publisher","first-page":"102544","DOI":"10.1016\/j.redox.2022.102544","volume":"58","author":"T Tian","year":"2022","unstructured":"Tian T, Lu Y, Lin J, Chen M, Qiu H, Zhu W, et al. CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis. Redox Biol. 2022;58:102544. https:\/\/doi.org\/10.1016\/j.redox.2022.102544.","journal-title":"Redox Biol"},{"key":"2690_CR144","doi-asserted-by":"publisher","first-page":"14752","DOI":"10.1038\/srep14752","volume":"5","author":"A Nath","year":"2015","unstructured":"Nath A, Li I, Roberts LR, Chan C. Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Sci Rep. 2015;5:14752. https:\/\/doi.org\/10.1038\/srep14752.","journal-title":"Sci Rep"},{"key":"2690_CR145","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12967-019-2098-6","volume":"17","author":"M Deng","year":"2019","unstructured":"Deng M, Cai X, Long L, Xie L, Ma H, Zhou Y, et al. CD36 promotes the epithelial-mesenchymal transition and metastasis in cervical cancer by interacting with TGF-\u03b2. J Transl Med. 2019;17:352. https:\/\/doi.org\/10.1186\/s12967-019-2098-6.","journal-title":"J Transl Med"},{"key":"2690_CR146","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s13402-025-01081-6","volume":"48","author":"H Lee","year":"2025","unstructured":"Lee H, Park S, Lee J, Lee C, Kang H, Kang J, et al. Lipid metabolism in cancer stem cells: reprogramming, mechanisms, crosstalk, and therapeutic approaches. Cell Oncol (Dordr) Dordrecht Neth. 2025;48:1181\u2013201. https:\/\/doi.org\/10.1007\/s13402-025-01081-6.","journal-title":"Cell Oncol (Dordr) Dordrecht Neth"},{"key":"2690_CR147","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41586-020-2428-0","volume":"584","author":"M Oginuma","year":"2020","unstructured":"Oginuma M, Harima Y, Tarazona OA, Diaz-Cuadros M, Michaut A, Ishitani T, et al. Intracellular pH controls WNT downstream of glycolysis in amniote embryos. Nature. 2020;584:98\u2013101. https:\/\/doi.org\/10.1038\/s41586-020-2428-0.","journal-title":"Nature"},{"key":"2690_CR148","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/ijms20112767","volume":"20","author":"Y Hao","year":"2019","unstructured":"Hao Y, Baker D, Ten Dijke P. TGF-\u03b2-Mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20:2767. https:\/\/doi.org\/10.3390\/ijms20112767.","journal-title":"Int J Mol Sci"},{"key":"2690_CR149","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009;19:156\u201372. https:\/\/doi.org\/10.1038\/cr.2009.5.","journal-title":"Cell Res"},{"key":"2690_CR150","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","volume":"6","author":"R-M Liu","year":"2015","unstructured":"Liu R-M, Desai LP. Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: a perverse cycle for fibrosis. Redox Biol. 2015;6:565\u201377. https:\/\/doi.org\/10.1016\/j.redox.2015.09.009.","journal-title":"Redox Biol"},{"key":"2690_CR151","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1038\/onc.2014.321","volume":"34","author":"L Jiang","year":"2015","unstructured":"Jiang L, Xiao L, Sugiura H, Huang X, Ali A, Kuro-o M, et al. Metabolic reprogramming during TGF\u03b21-induced epithelial-to-mesenchymal transition. Oncogene. 2015;34:3908\u201316. https:\/\/doi.org\/10.1038\/onc.2014.321.","journal-title":"Oncogene"},{"key":"2690_CR152","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/ijms23020800","volume":"23","author":"M Fedele","year":"2022","unstructured":"Fedele M, Sgarra R, Battista S, Cerchia L, Manfioletti G. The epithelial-mesenchymal transition at the crossroads between metabolism and tumor progression. Int J Mol Sci. 2022;23:800. https:\/\/doi.org\/10.3390\/ijms23020800.","journal-title":"Int J Mol Sci"},{"key":"2690_CR153","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ccr.2013.01.022","volume":"23","author":"C Dong","year":"2013","unstructured":"Dong C, Yuan T, Wu Y, Wang Y, Fan TWM, Miriyala S, et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell. 2013;23:316\u201331. https:\/\/doi.org\/10.1016\/j.ccr.2013.01.022.","journal-title":"Cancer Cell"},{"key":"2690_CR154","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2049-3002-2-11","volume":"2","author":"M Masin","year":"2014","unstructured":"Masin M, Vazquez J, Rossi S, Groeneveld S, Samson N, Schwalie PC, et al. GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer. Cancer Metab. 2014;2:11. https:\/\/doi.org\/10.1186\/2049-3002-2-11.","journal-title":"Cancer Metab"},{"key":"2690_CR155","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1158\/0008-5472.CAN-12-0448","volume":"72","author":"T-K Ha","year":"2012","unstructured":"Ha T-K, Her N-G, Lee M-G, Ryu B-K, Lee J-H, Han J, et al. Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription. Cancer Res. 2012;72:4097\u2013109. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-0448.","journal-title":"Cancer Res"},{"key":"2690_CR156","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2049-3002-2-20","volume":"2","author":"Y Sun","year":"2014","unstructured":"Sun Y, Daemen A, Hatzivassiliou G, Arnott D, Wilson C, Zhuang G, et al. Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells. Cancer Metab. 2014;2:20. https:\/\/doi.org\/10.1186\/2049-3002-2-20.","journal-title":"Cancer Metab"},{"key":"2690_CR157","doi-asserted-by":"publisher","first-page":"15526","DOI":"10.1073\/pnas.1407717111","volume":"111","author":"A Hamabe","year":"2014","unstructured":"Hamabe A, Konno M, Tanuma N, Shima H, Tsunekuni K, Kawamoto K, et al. Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition. Proc Natl Acad Sci U S A. 2014;111:15526\u201331. https:\/\/doi.org\/10.1073\/pnas.1407717111.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2690_CR158","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1111\/febs.14201","volume":"284","author":"A Rodr\u00edguez-Garc\u00eda","year":"2017","unstructured":"Rodr\u00edguez-Garc\u00eda A, Sams\u00f3 P, Fontova P, Simon-Molas H, Manzano A, Casta\u00f1o E, et al. TGF-\u03b21 targets Smad, p38 MAPK, and PI3K\/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells. FEBS J. 2017;284:3437\u201354. https:\/\/doi.org\/10.1111\/febs.14201.","journal-title":"FEBS J"},{"key":"2690_CR159","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.bbrc.2017.01.178","volume":"484","author":"A Yalcin","year":"2017","unstructured":"Yalcin A, Solakoglu TH, Ozcan SC, Guzel S, Peker S, Celikler S, et al. 6-phosphofructo-2-kinase\/fructose 2,6-bisphosphatase-3 is required for transforming growth factor \u03b21-enhanced invasion of Panc1 cells in vitro. Biochem Biophys Res Commun. 2017;484:687\u201393. https:\/\/doi.org\/10.1016\/j.bbrc.2017.01.178.","journal-title":"Biochem Biophys Res Commun"},{"key":"2690_CR160","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1038\/s42003-024-07408-7","volume":"7","author":"R Bhowmick","year":"2024","unstructured":"Bhowmick R, Campit S, Katkam SK, Keshamouni VG, Chandrasekaran S. Genome-scale modeling identifies dynamic metabolic vulnerabilities during the epithelial to mesenchymal transition. Commun Biol. 2024;7:1704. https:\/\/doi.org\/10.1038\/s42003-024-07408-7.","journal-title":"Commun Biol"},{"key":"2690_CR161","doi-asserted-by":"publisher","first-page":"14374","DOI":"10.1038\/ncomms14374","volume":"8","author":"NH Kim","year":"2017","unstructured":"Kim NH, Cha YH, Lee J, Lee S-H, Yang JH, Yun JS, et al. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress. Nat Commun. 2017;8:14374. https:\/\/doi.org\/10.1038\/ncomms14374.","journal-title":"Nat Commun"},{"key":"2690_CR162","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1039\/c5mb00413f","volume":"11","author":"N Dalmau","year":"2015","unstructured":"Dalmau N, Jaumot J, Tauler R, Bedia C. Epithelial-to-mesenchymal transition involves triacylglycerol accumulation in DU145 prostate cancer cells. Mol Biosyst. 2015;11:3397\u2013406. https:\/\/doi.org\/10.1039\/c5mb00413f.","journal-title":"Mol Biosyst"},{"key":"2690_CR163","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2014.07.032","volume":"158","author":"YD Shaul","year":"2014","unstructured":"Shaul YD, Freinkman E, Comb WC, Cantor JR, Tam WL, Thiru P, et al. Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition. Cell. 2014;158:1094\u2013109. https:\/\/doi.org\/10.1016\/j.cell.2014.07.032.","journal-title":"Cell"},{"key":"2690_CR164","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1158\/0008-5472.CAN-10-0965","volume":"71","author":"A Ahmad","year":"2011","unstructured":"Ahmad A, Aboukameel A, Kong D, Wang Z, Sethi S, Chen W, et al. Phosphoglucose isomerase\/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res. 2011;71:3400\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0965.","journal-title":"Cancer Res"},{"key":"2690_CR165","doi-asserted-by":"publisher","first-page":"e85804","DOI":"10.1371\/journal.pone.0085804","volume":"9","author":"S Du","year":"2014","unstructured":"Du S, Guan Z, Hao L, Song Y, Wang L, Gong L, et al. Fructose-bisphosphate aldolase a is a potential metastasis-associated marker of lung squamous cell carcinoma and promotes lung cell tumorigenesis and migration. PLoS ONE. 2014;9:e85804. https:\/\/doi.org\/10.1371\/journal.pone.0085804.","journal-title":"PLoS ONE"},{"key":"2690_CR166","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3892\/ijo.2016.3774","volume":"50","author":"K Liu","year":"2017","unstructured":"Liu K, Tang Z, Huang A, Chen P, Liu P, Yang J, et al. Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression. Int J Oncol. 2017;50:252\u201362. https:\/\/doi.org\/10.3892\/ijo.2016.3774.","journal-title":"Int J Oncol"},{"key":"2690_CR167","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.bbrc.2015.12.078","volume":"469","author":"F Jiang","year":"2016","unstructured":"Jiang F, Ma S, Xue Y, Hou J, Zhang Y. LDH-A promotes malignant progression via activation of epithelial-to-mesenchymal transition and conferring stemness in muscle-invasive bladder cancer. Biochem Biophys Res Commun. 2016;469:985\u201392. https:\/\/doi.org\/10.1016\/j.bbrc.2015.12.078.","journal-title":"Biochem Biophys Res Commun"},{"key":"2690_CR168","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3892\/etm.2018.6189","volume":"16","author":"J Wu","year":"2018","unstructured":"Wu J, Chen J, Xi Y, Wang F, Sha H, Luo L, et al. High glucose induces epithelial-mesenchymal transition and results in the migration and invasion of colorectal cancer cells. Exp Ther Med. 2018;16:222\u201330. https:\/\/doi.org\/10.3892\/etm.2018.6189.","journal-title":"Exp Ther Med"},{"key":"2690_CR169","doi-asserted-by":"publisher","first-page":"10391","DOI":"10.1111\/jcmm.15653","volume":"24","author":"S Li","year":"2020","unstructured":"Li S, Zhu H, Chen H, Xia J, Zhang F, Xu R, et al. Glucose promotes epithelial-mesenchymal transitions in bladder cancer by regulating the functions of YAP1 and TAZ. J Cell Mol Med. 2020;24:10391\u2013401. https:\/\/doi.org\/10.1111\/jcmm.15653.","journal-title":"J Cell Mol Med"},{"key":"2690_CR170","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1111\/jcmm.17943","volume":"27","author":"S Li","year":"2023","unstructured":"Li S, Ruan B, Wang Z, Xia J, Lin Q, Xu R, et al. Glucose dysregulation promotes oncogenesis in human bladder cancer by regulating autophagy and YAP1\/TAZ expression. J Cell Mol Med. 2023;27:3744\u201359. https:\/\/doi.org\/10.1111\/jcmm.17943.","journal-title":"J Cell Mol Med"},{"key":"2690_CR171","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature19353","volume":"537","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli M, Gon\u00e7alves E, Johnson TI, Zecchini VR, da Costa ASH, Gaude E, et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature. 2016;537:544\u20137. https:\/\/doi.org\/10.1038\/nature19353.","journal-title":"Nature"},{"key":"2690_CR172","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nature20144","volume":"540","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli M, Gon\u00e7alves E, Johnson TI, Zecchini VR, da Costa ASH, Gaude E, et al. Corrigendum: Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature. 2016;540:150. https:\/\/doi.org\/10.1038\/nature20144.","journal-title":"Nature"},{"key":"2690_CR173","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1158\/0008-5472.CAN-16-0268","volume":"76","author":"X He","year":"2016","unstructured":"He X, Yan B, Liu S, Jia J, Lai W, Xin X, et al. Chromatin remodeling factor lsh drives cancer progression by suppressing the activity of fumarate hydratase. Cancer Res. 2016;76:5743\u201355. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0268.","journal-title":"Cancer Res"},{"key":"2690_CR174","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1158\/0008-5472.CAN-22-0457","volume":"82","author":"X He","year":"2022","unstructured":"He X, Yan B, Liu S, Jia J, Lai W, Xin X, et al. Correction: chromatin remodeling factor lsh drives cancer progression by suppressing the activity of fumarate hydratase. Cancer Res. 2022;82:1435. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0457.","journal-title":"Cancer Res"},{"key":"2690_CR175","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.tranon.2016.09.009","volume":"9","author":"H Wang","year":"2016","unstructured":"Wang H, Chen Y, Wu G. SDHB deficiency promotes TGF\u03b2-mediated invasion and metastasis of colorectal cancer through transcriptional repression complex SNAIL1-SMAD3\/4. Transl Oncol. 2016;9:512\u201320. https:\/\/doi.org\/10.1016\/j.tranon.2016.09.009.","journal-title":"Transl Oncol"},{"key":"2690_CR176","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2049-3002-2-21","volume":"2","author":"P-JP Aspuria","year":"2014","unstructured":"Aspuria P-JP, Lunt SY, V\u00e4remo L, Vergnes L, Gozo M, Beach JA, et al. Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism. Cancer Metab. 2014;2:21. https:\/\/doi.org\/10.1186\/2049-3002-2-21.","journal-title":"Cancer Metab"},{"key":"2690_CR177","doi-asserted-by":"publisher","first-page":"29965","DOI":"10.1074\/jbc.M113.450106","volume":"288","author":"J Liu","year":"2013","unstructured":"Liu J, Gao L, Zhang H, Wang D, Wang M, Zhu J, et al. Succinate dehydrogenase 5 (SDH5) regulates glycogen synthase kinase 3\u03b2-\u03b2-catenin-mediated lung cancer metastasis. J Biol Chem. 2013;288:29965\u201373. https:\/\/doi.org\/10.1074\/jbc.M113.450106.","journal-title":"J Biol Chem"},{"key":"2690_CR178","doi-asserted-by":"publisher","first-page":"42180","DOI":"10.1074\/jbc.M112.417832","volume":"287","author":"AR Grassian","year":"2012","unstructured":"Grassian AR, Lin F, Barrett R, Liu Y, Jiang W, Korpal M, et al. Isocitrate dehydrogenase (IDH) mutations promote a reversible ZEB1\/microRNA (miR)-200-dependent epithelial-mesenchymal transition (EMT). J Biol Chem. 2012;287:42180\u201394. https:\/\/doi.org\/10.1074\/jbc.M112.417832.","journal-title":"J Biol Chem"},{"key":"2690_CR179","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Cui L, Lu S, Xu S. Amino acid metabolism in tumor biology and therapy. Cell Death Dis. 2024;15:42. https:\/\/doi.org\/10.1038\/s41419-024-06435-w.","journal-title":"Cell Death Dis"},{"key":"2690_CR180","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.18632\/oncotarget.6879","volume":"7","author":"SY Lee","year":"2016","unstructured":"Lee SY, Jeon HM, Ju MK, Jeong EK, Kim CH, Park HG, et al. Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch. Oncotarget. 2016;7:7925\u201339. https:\/\/doi.org\/10.18632\/oncotarget.6879.","journal-title":"Oncotarget"},{"key":"2690_CR181","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.3390\/cancers11101610","volume":"11","author":"E Ramirez-Pe\u00f1a","year":"2019","unstructured":"Ramirez-Pe\u00f1a E, Arnold J, Shivakumar V, Joseph R, Vidhya Vijay G, den Hollander P, et al. The epithelial to mesenchymal transition promotes glutamine independence by suppressing GLS2 expression. Cancers (Basel). 2019;11:1610. https:\/\/doi.org\/10.3390\/cancers11101610.","journal-title":"Cancers (Basel)"},{"key":"2690_CR182","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41388-019-1007-z","volume":"39","author":"MM Dias","year":"2020","unstructured":"Dias MM, Adamoski D, Dos Reis LM, Ascen\u00e7\u00e3o CFR, de Oliveira KRS, Mafra ACP, et al. GLS2 is protumorigenic in breast cancers. Oncogene. 2020;39:690\u2013702. https:\/\/doi.org\/10.1038\/s41388-019-1007-z.","journal-title":"Oncogene"},{"key":"2690_CR183","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12967-015-0500-6","volume":"13","author":"G Liu","year":"2015","unstructured":"Liu G, Zhu J, Yu M, Cai C, Zhou Y, Yu M, et al. Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients. J Transl Med. 2015;13:144. https:\/\/doi.org\/10.1186\/s12967-015-0500-6.","journal-title":"J Transl Med"},{"key":"2690_CR184","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12672-025-04297-y","volume":"17","author":"MJ Al-khreisat","year":"2025","unstructured":"Al-khreisat MJ, Abdulsahib WK, Jasim IK, Malathi H, Nayak PP, Anand DA, et al. Targeting cancer stem cell plasticity and tumor microenvironment crosstalk: a comprehensive review. Discov Onc. 2025;17:145. https:\/\/doi.org\/10.1007\/s12672-025-04297-y.","journal-title":"Discov Onc"},{"key":"2690_CR185","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE De Visser","year":"2023","unstructured":"De Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"key":"2690_CR186","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1593\/neo.131114","volume-title":"Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events","author":"DJ Junk","year":"2013","unstructured":"Junk DJ, Cipriano R, Bryson BL, Gilmore HL, Jackson MW. Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events. Volume 15. New York, N: Neoplasia; 2013. pp. 1100\u20139. https:\/\/doi.org\/10.1593\/neo.131114."},{"key":"2690_CR187","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019;18:70. https:\/\/doi.org\/10.1186\/s12943-019-0994-2.","journal-title":"Mol Cancer"},{"key":"2690_CR188","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1038\/s41598-023-28480-9","volume":"13","author":"PM Szabo","year":"2023","unstructured":"Szabo PM, Vajdi A, Kumar N, Tolstorukov MY, Chen BJ, Edwards R, et al. Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment. Sci Rep. 2023;13:3051. https:\/\/doi.org\/10.1038\/s41598-023-28480-9.","journal-title":"Sci Rep"},{"key":"2690_CR189","doi-asserted-by":"publisher","first-page":"702021","DOI":"10.3389\/fcell.2021.702021","volume":"9","author":"JS Fang","year":"2021","unstructured":"Fang JS, Hultgren NW, Hughes CCW. Regulation of partial and reversible endothelial-to-mesenchymal transition in angiogenesis. Front Cell Dev Biol. 2021;9:702021. https:\/\/doi.org\/10.3389\/fcell.2021.702021.","journal-title":"Front Cell Dev Biol"},{"key":"2690_CR190","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","volume":"24","author":"X Wu","year":"2025","unstructured":"Wu X, Que H, Li Q, Wei X. Wnt\/\u03b2-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy. Mol Cancer. 2025;24:171. https:\/\/doi.org\/10.1186\/s12943-025-02363-1.","journal-title":"Mol Cancer"},{"key":"2690_CR191","doi-asserted-by":"publisher","first-page":"11724","DOI":"10.3390\/ijms262311724","volume":"26","author":"R Kim","year":"2025","unstructured":"Kim R, Chang W. Endothelial-to-mesenchymal transition in health and disease: molecular insights and therapeutic implications. IJMS. 2025;26:11724. https:\/\/doi.org\/10.3390\/ijms262311724.","journal-title":"IJMS"},{"key":"2690_CR192","doi-asserted-by":"publisher","first-page":"e23833","DOI":"10.1371\/journal.pone.0023833","volume":"6","author":"V Sigurdsson","year":"2011","unstructured":"Sigurdsson V, Hilmarsdottir B, Sigmundsdottir H, Fridriksdottir AJR, Ringn\u00e9r M, Villadsen R et al. A <>Swarbrick editor 2011 endothelial induced EMT in breast epithelial cells with stem cell properties. PLoS ONE 6 e23833 https:\/\/doi.org\/10.1371\/journal.pone.0023833.","journal-title":"PLoS ONE"},{"key":"2690_CR193","doi-asserted-by":"publisher","first-page":"1509195","DOI":"10.3389\/fimmu.2024.1509195","volume":"15","author":"T Yan","year":"2024","unstructured":"Yan T, Shi J. Angiogenesis and EMT regulators in the tumor microenvironment in lung cancer and immunotherapy. Front Immunol. 2024;15:1509195. https:\/\/doi.org\/10.3389\/fimmu.2024.1509195.","journal-title":"Front Immunol"},{"key":"2690_CR194","doi-asserted-by":"publisher","first-page":"11385","DOI":"10.1038\/ncomms11385","volume":"7","author":"Y Yang","year":"2016","unstructured":"Yang Y, Andersson P, Hosaka K, Zhang Y, Cao R, Iwamoto H, et al. The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages. Nat Commun. 2016;7:11385. https:\/\/doi.org\/10.1038\/ncomms11385.","journal-title":"Nat Commun"},{"key":"2690_CR195","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1608384113","author":"K Hosaka","year":"2016","unstructured":"Hosaka K, Yang Y, Seki T, Fischer C, Dubey O, Fredlund E, et al. Pericyte\u2013fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci USA. 2016. https:\/\/doi.org\/10.1073\/pnas.1608384113. cited 2026 Jan 28;113.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2690_CR196","doi-asserted-by":"publisher","first-page":"698275","DOI":"10.3389\/fphar.2021.698275","volume":"12","author":"F Feng","year":"2021","unstructured":"Feng F, Feng X, Zhang D, Li Q, Yao L. Matrix stiffness induces pericyte-fibroblast transition through YAP activation. Front Pharmacol. 2021;12:698275. https:\/\/doi.org\/10.3389\/fphar.2021.698275.","journal-title":"Front Pharmacol"},{"key":"2690_CR197","doi-asserted-by":"publisher","first-page":"1571583","DOI":"10.3389\/fonc.2025.1571583","volume":"15","author":"L Liao","year":"2025","unstructured":"Liao L, Wang Y-X, Fan S-S, Hu Y-Y, Wang X-C, Zhang X. The role and clinical significance of tumor-associated macrophages in the epithelial\u2013mesenchymal transition of lung cancer. Front Oncol. 2025;15:1571583. https:\/\/doi.org\/10.3389\/fonc.2025.1571583.","journal-title":"Front Oncol"},{"key":"2690_CR198","doi-asserted-by":"publisher","first-page":"8334","DOI":"10.3390\/ijms22158334","volume":"22","author":"A Abaurrea","year":"2021","unstructured":"Abaurrea A, Araujo AM, Caffarel MM. The Role of the IL-6 Cytokine family in epithelial-mesenchymal plasticity in cancer progression. Int J Mol Sci. 2021;22:8334. https:\/\/doi.org\/10.3390\/ijms22158334.","journal-title":"Int J Mol Sci"},{"key":"2690_CR199","doi-asserted-by":"publisher","first-page":"1382256","DOI":"10.3389\/fphar.2024.1382256","volume":"15","author":"Z Li","year":"2024","unstructured":"Li Z, Duan D, Li L, Peng D, Ming Y, Ni R, et al. Tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress. Front Pharmacol. 2024;15:1382256. https:\/\/doi.org\/10.3389\/fphar.2024.1382256.","journal-title":"Front Pharmacol"},{"key":"2690_CR200","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fcell.2018.00168","volume":"6","author":"JL Sieow","year":"2018","unstructured":"Sieow JL, Gun SY, Wong SC. The sweet surrender: how myeloid cell metabolic plasticity shapes the tumor microenvironment. Front Cell Dev Biol. 2018;6:168. https:\/\/doi.org\/10.3389\/fcell.2018.00168.","journal-title":"Front Cell Dev Biol"},{"key":"2690_CR201","doi-asserted-by":"publisher","first-page":"101668","DOI":"10.1016\/j.smim.2022.101668","volume":"61\u201364","author":"N Tumino","year":"2022","unstructured":"Tumino N, Fiore PF, Pelosi A, Moretta L, Vacca P. Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells. Semin Immunol. 2022;61\u201364:101668. https:\/\/doi.org\/10.1016\/j.smim.2022.101668.","journal-title":"Semin Immunol"},{"key":"2690_CR202","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41392-020-00313-5","volume":"5","author":"S Qin","year":"2020","unstructured":"Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, et al. Emerging role of tumor cell plasticity in modifying therapeutic response. Sig Transduct Target Ther. 2020;5:228. https:\/\/doi.org\/10.1038\/s41392-020-00313-5.","journal-title":"Sig Transduct Target Ther"},{"key":"2690_CR203","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.celrep.2013.11.014","volume":"5","author":"M Stankic","year":"2013","unstructured":"Stankic M, Pavlovic S, Chin Y, Brogi E, Padua D, Norton L, et al. TGF-\u03b2-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition. Cell Rep. 2013;5:1228\u201342. https:\/\/doi.org\/10.1016\/j.celrep.2013.11.014.","journal-title":"Cell Rep"},{"key":"2690_CR204","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/cells8111387","volume":"8","author":"E Oh","year":"2019","unstructured":"Oh E, Hong J, Yun C-O. Regulatory T Cells induce metastasis by increasing Tgf-\u03b2 and enhancing the epithelial\u2013mesenchymal transition. Cells. 2019;8:1387. https:\/\/doi.org\/10.3390\/cells8111387.","journal-title":"Cells"},{"key":"2690_CR205","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12307-019-00232-2","volume":"12","author":"L Lorenzo-Sanz","year":"2019","unstructured":"Lorenzo-Sanz L, Mu\u00f1oz P. Tumor-infiltrating immunosuppressive cells in cancer-cell plasticity, tumor progression and therapy response. Cancer Microenviron. 2019;12:119\u201332. https:\/\/doi.org\/10.1007\/s12307-019-00232-2.","journal-title":"Cancer Microenviron"},{"key":"2690_CR206","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00018-016-2156-7","volume":"73","author":"V Chopin","year":"2016","unstructured":"Chopin V, Lagadec C, Toillon R-A, Le Bourhis X. Neurotrophin signaling in cancer stem cells. Cell Mol Life Sci. 2016;73:1859\u201370. https:\/\/doi.org\/10.1007\/s00018-016-2156-7.","journal-title":"Cell Mol Life Sci"},{"key":"2690_CR207","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","volume":"623","author":"KR Taylor","year":"2023","unstructured":"Taylor KR, Barron T, Hui A, Spitzer A, Yal\u00e7in B, Ivec AE, et al. Glioma synapses recruit mechanisms of adaptive plasticity. Nature. 2023;623:366\u201374. https:\/\/doi.org\/10.1038\/s41586-023-06678-1.","journal-title":"Nature"},{"key":"2690_CR208","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","volume":"361","author":"LF Reichardt","year":"2006","unstructured":"Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci. 2006;361:1545\u201364. https:\/\/doi.org\/10.1098\/rstb.2006.1894.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2690_CR209","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.4161\/cc.24759","volume":"12","author":"A Ricci","year":"2013","unstructured":"Ricci A, De Vitis C, Noto A, Fattore L, Mariotta S, Cherubini E, et al. TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung. Cell Cycle Georget Tex. 2013;12:1696\u2013703. https:\/\/doi.org\/10.4161\/cc.24759.","journal-title":"Cell Cycle Georget Tex"},{"key":"2690_CR210","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9854","author":"L Meng","year":"2018","unstructured":"Meng L, Liu B, Ji R, Jiang X, Yan X, Xin Y. Targeting the BDNF\/TrkB pathway for the treatment of tumors (Review). Oncol Lett . 2018 https:\/\/doi.org\/10.3892\/ol.2018.9854 cited 2026 Jan 30."},{"key":"2690_CR211","doi-asserted-by":"publisher","first-page":"113049","DOI":"10.1016\/j.yexcr.2022.113049","volume":"413","author":"S Wang","year":"2022","unstructured":"Wang S, Nie L, Song Y, Zhang F, Chen X, Shi W, et al. Neurturin promotes tumor cell motility and angiogenesis in colorectal cancer. Exp Cell Res. 2022;413:113049. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113049.","journal-title":"Exp Cell Res"},{"key":"2690_CR212","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12967-025-06306-8","volume":"23","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Fu Q, Sun W, Yue Q, He P, Niu D, et al. Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches. J Transl Med. 2025;23:313. https:\/\/doi.org\/10.1186\/s12967-025-06306-8.","journal-title":"J Transl Med"},{"key":"2690_CR213","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ncb2756","volume":"15","author":"F Calvo","year":"2013","unstructured":"Calvo F, Ege N, Grande-Garcia A, Hooper S, Jenkins RP, Chaudhry SI, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15:637\u201346. https:\/\/doi.org\/10.1038\/ncb2756.","journal-title":"Nat Cell Biol"},{"key":"2690_CR214","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3390\/cancers13143466","volume":"13","author":"I Belhabib","year":"2021","unstructured":"Belhabib I, Zaghdoudi S, Lac C, Bousquet C, Jean C. Extracellular matrices and cancer-associated fibroblasts: targets for cancer diagnosis and therapy? Cancers. 2021;13:3466. https:\/\/doi.org\/10.3390\/cancers13143466.","journal-title":"Cancers"},{"key":"2690_CR215","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.tcb.2017.03.003","volume":"27","author":"RJ Eddy","year":"2017","unstructured":"Eddy RJ, Weidmann MD, Sharma VP, Condeelis JS. Tumor cell invadopodia: invasive protrusions that orchestrate metastasis. Trends Cell Biol. 2017;27:595\u2013607. https:\/\/doi.org\/10.1016\/j.tcb.2017.03.003.","journal-title":"Trends Cell Biol"},{"key":"2690_CR216","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Sig Transduct Target Ther. 2023;8:70. https:\/\/doi.org\/10.1038\/s41392-023-01332-8.","journal-title":"Sig Transduct Target Ther"},{"key":"2690_CR217","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/ijc.29519","volume":"138","author":"K Balamurugan","year":"2016","unstructured":"Balamurugan K. HIF -1 at the crossroads of hypoxia, inflammation, and cancer. Intl J Cancer. 2016;138:1058\u201366. https:\/\/doi.org\/10.1002\/ijc.29519.","journal-title":"Intl J Cancer"},{"key":"2690_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpt.2025.07.003","author":"AH Shaikat","year":"2025","unstructured":"Shaikat AH, Azad SMAK, Tamim MAR, Ullah MS, Amin MN, Sabbir MK, et al. Investigating hypoxia-inducible factor signaling in cancer: mechanisms, clinical implications, targeted therapeutic strategies, and resistance. Cancer Pathogenesis Therapy. 2025. https:\/\/doi.org\/10.1016\/j.cpt.2025.07.003. S2949713225000904.","journal-title":"Cancer Pathogenesis Therapy"},{"key":"2690_CR219","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bpj.2020.07.003","volume":"119","author":"J Chang","year":"2020","unstructured":"Chang J, Pang EM, Adebowale K, Wisdom KM, Chaudhuri O. Increased stiffness inhibits invadopodia formation and cell migration in 3D. Biophys J. 2020;119:726\u201336. https:\/\/doi.org\/10.1016\/j.bpj.2020.07.003.","journal-title":"Biophys J"},{"key":"2690_CR220","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1038\/s41388-021-01728-2","volume":"40","author":"H Esquer","year":"2021","unstructured":"Esquer H, Zhou Q, Nemkov T, Abraham AD, Rinaldetti S, Chen Y-C, et al. Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer. Oncogene. 2021;40:2884\u201397. https:\/\/doi.org\/10.1038\/s41388-021-01728-2.","journal-title":"Oncogene"},{"key":"2690_CR221","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/s41388-021-01708-6","volume":"40","author":"PN Gollavilli","year":"2021","unstructured":"Gollavilli PN, Parma B, Siddiqui A, Yang H, Ramesh V, Napoli F, et al. The role of miR-200b\/c in balancing EMT and proliferation revealed by an activity reporter. Oncogene. 2021;40:2309\u201322. https:\/\/doi.org\/10.1038\/s41388-021-01708-6.","journal-title":"Oncogene"},{"key":"2690_CR222","doi-asserted-by":"publisher","first-page":"102305","DOI":"10.1016\/j.xpro.2023.102305","volume":"4","author":"N Rimmer","year":"2023","unstructured":"Rimmer N, Liang C-Y, Coelho R, Lopez MN, Jacob F. Generation of endogenously tagged E-cadherin cells using gene editing via non-homologous end joining. STAR Protoc. 2023;4:102305. https:\/\/doi.org\/10.1016\/j.xpro.2023.102305.","journal-title":"STAR Protoc"},{"key":"2690_CR223","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1091\/mbc.E17-03-0209","volume":"28","author":"B Roberts","year":"2017","unstructured":"Roberts B, Haupt A, Tucker A, Grancharova T, Arakaki J, Fuqua MA, et al. Systematic gene tagging using CRISPR\/Cas9 in human stem cells to illuminate cell organization. Mol Biol Cell. 2017;28:2854\u201374. https:\/\/doi.org\/10.1091\/mbc.E17-03-0209.","journal-title":"Mol Biol Cell"},{"key":"2690_CR224","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.celrep.2018.10.097","volume":"25","author":"S Lee","year":"2018","unstructured":"Lee S, Cieply B, Yang Y, Peart N, Glaser C, Chan P, et al. Esrp1-Regulated splicing of arhgef11 isoforms is required for epithelial tight junction integrity. Cell Rep. 2018;25:2417\u2013e24305. https:\/\/doi.org\/10.1016\/j.celrep.2018.10.097.","journal-title":"Cell Rep"},{"key":"2690_CR225","doi-asserted-by":"publisher","first-page":"031908","DOI":"10.1063\/1.5024874","volume":"2","author":"MK Jolly","year":"2018","unstructured":"Jolly MK, Preca B-T, Tripathi SC, Jia D, George JT, Hanash SM, et al. Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer. APL Bioeng. 2018;2:031908. https:\/\/doi.org\/10.1063\/1.5024874.","journal-title":"APL Bioeng"},{"key":"2690_CR226","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1038\/oncsis.2016.83","volume":"6","author":"J Xiang","year":"2017","unstructured":"Xiang J, Fu X, Ran W, Wang Z. Grhl2 reduces invasion and migration through inhibition of TGF\u03b2-induced EMT in gastric cancer. Oncogenesis. 2017;6:e284. https:\/\/doi.org\/10.1038\/oncsis.2016.83.","journal-title":"Oncogenesis"},{"key":"2690_CR227","doi-asserted-by":"publisher","first-page":"e1004569","DOI":"10.1371\/journal.pcbi.1004569","volume":"11","author":"T Hong","year":"2015","unstructured":"Hong T, Watanabe K, Ta CH, Villarreal-Ponce A, Nie Q, Dai X. An Ovol2-Zeb1 mutual inhibitory circuit governs bidirectional and multi-step transition between epithelial and mesenchymal states. PLoS Comput Biol. 2015;11:e1004569. https:\/\/doi.org\/10.1371\/journal.pcbi.1004569.","journal-title":"PLoS Comput Biol"},{"key":"2690_CR228","doi-asserted-by":"publisher","first-page":"1327772","DOI":"10.3389\/fcell.2024.1327772","volume":"12","author":"K Kumano","year":"2024","unstructured":"Kumano K, Nakahashi H, Louphrasitthiphol P, Kuroda Y, Miyazaki Y, Shimomura O, et al. Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer. Front Cell Dev Biol. 2024;12:1327772. https:\/\/doi.org\/10.3389\/fcell.2024.1327772.","journal-title":"Front Cell Dev Biol"},{"key":"2690_CR229","doi-asserted-by":"publisher","first-page":"1205157","DOI":"10.3389\/fbioe.2023.1205157","volume":"11","author":"X Zeng","year":"2023","unstructured":"Zeng X, Ma Q, Li X-K, You L-T, Li J, Fu X, et al. Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications. Front Bioeng Biotechnol. 2023;11:1205157. https:\/\/doi.org\/10.3389\/fbioe.2023.1205157.","journal-title":"Front Bioeng Biotechnol"},{"key":"2690_CR230","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/cancers13040737","volume":"13","author":"F Duzagac","year":"2021","unstructured":"Duzagac F, Saorin G, Memeo L, Canzonieri V, Rizzolio F. Microfluidic organoids-on-a-chip: quantum leap in cancer research. Cancers (Basel). 2021;13:737. https:\/\/doi.org\/10.3390\/cancers13040737.","journal-title":"Cancers (Basel)"},{"key":"2690_CR231","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.3390\/cancers13122970","volume":"13","author":"F Fontana","year":"2021","unstructured":"Fontana F, Marzagalli M, Sommariva M, Gagliano N, Limonta P. Vitro 3D Cultures to model the tumor microenvironment. Cancers (Basel). 2021;13:2970. https:\/\/doi.org\/10.3390\/cancers13122970.","journal-title":"Cancers (Basel)"},{"key":"2690_CR232","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/ijms26031028","volume":"26","author":"M Testa","year":"2025","unstructured":"Testa M, Gaggianesi M, D\u2019Accardo C, Porcelli G, Turdo A, Di Marco C, et al. A Novel Tumor on chip mimicking the breast cancer microenvironment for dynamic drug screening. IJMS. 2025;26:1028. https:\/\/doi.org\/10.3390\/ijms26031028.","journal-title":"IJMS"},{"key":"2690_CR233","doi-asserted-by":"publisher","first-page":"1470379","DOI":"10.3389\/fonc.2024.1470379","volume":"14","author":"N Bar-Hai","year":"2024","unstructured":"Bar-Hai N, Ben-Yishay R, Arbili-Yarhi S, Herman N, Avidan-Noy V, Menes T, et al. Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids. Front Oncol. 2024;14:1470379. https:\/\/doi.org\/10.3389\/fonc.2024.1470379.","journal-title":"Front Oncol"},{"key":"2690_CR234","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/mi15121444","volume":"15","author":"A Ajikumar","year":"2024","unstructured":"Ajikumar A, Lei KF. Microfluidic technologies in advancing cancer research. micromachines (Basel). 2024;15:1444. https:\/\/doi.org\/10.3390\/mi15121444.","journal-title":"Micromachines (Basel)"},{"key":"2690_CR235","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.trecan.2022.03.006","volume":"8","author":"P Mehta","year":"2022","unstructured":"Mehta P, Rahman Z, Ten Dijke P, Boukany PE. Microfluidics meets 3D cancer cell migration. Trends Cancer. 2022;8:683\u201397. https:\/\/doi.org\/10.1016\/j.trecan.2022.03.006.","journal-title":"Trends Cancer"},{"key":"2690_CR236","doi-asserted-by":"publisher","first-page":"100933","DOI":"10.1016\/j.jbc.2021.100933","volume":"297","author":"B Guo","year":"2021","unstructured":"Guo B, Shi X, Ma Z, Ji M, Tang C, Wang F. A ratiometric dual luciferase reporter for quantitative monitoring of pre-mRNA splicing efficiency in vivo. J Biol Chem. 2021;297:100933. https:\/\/doi.org\/10.1016\/j.jbc.2021.100933.","journal-title":"J Biol Chem"},{"key":"2690_CR237","doi-asserted-by":"publisher","first-page":"e9085","DOI":"10.15252\/emmm.201809085","volume":"10","author":"Y Chen","year":"2018","unstructured":"Chen Y, LeBleu VS, Carstens JL, Sugimoto H, Zheng X, Malasi S, et al. Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program. EMBO Mol Med. 2018;10:e9085. https:\/\/doi.org\/10.15252\/emmm.201809085.","journal-title":"EMBO Mol Med"},{"key":"2690_CR238","doi-asserted-by":"publisher","first-page":"dmm034330","DOI":"10.1242\/dmm.034330","volume":"11","author":"O Ilina","year":"2018","unstructured":"Ilina O, Campanello L, Gritsenko PG, Vullings M, Wang C, Bult P, et al. Intravital microscopy of collective invasion plasticity in breast cancer. Dis Model Mech. 2018;11:dmm034330. https:\/\/doi.org\/10.1242\/dmm.034330.","journal-title":"Dis Model Mech"},{"key":"2690_CR239","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-15-2662","volume":"76","author":"Z Zhao","year":"2016","unstructured":"Zhao Z, Zhu X, Cui K, Mancuso J, Federley R, Fischer K, et al. In vivo visualization and characterization of epithelial-mesenchymal transition in breast tumors. Cancer Res. 2016;76:2094\u2013104. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2662.","journal-title":"Cancer Res"},{"key":"2690_CR240","doi-asserted-by":"publisher","DOI":"10.3791\/59633","author":"GS Karagiannis","year":"2019","unstructured":"Karagiannis GS, Pastoriza JM, Borriello L, Jafari R, Coste A, Condeelis JS, et al. Assessing tumor microenvironment of metastasis doorway-mediated vascular permeability associated with cancer cell dissemination using intravital imaging and fixed tissue analysis. J Vis Exp. 2019. https:\/\/doi.org\/10.3791\/59633.","journal-title":"J Vis Exp"},{"key":"2690_CR241","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1038\/s41467-021-27308-2","volume":"12","author":"VP Sharma","year":"2021","unstructured":"Sharma VP, Tang B, Wang Y, Duran CL, Karagiannis GS, Xue EA, et al. Live tumor imaging shows macrophage induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination. Nat Commun. 2021;12:7300. https:\/\/doi.org\/10.1038\/s41467-021-27308-2.","journal-title":"Nat Commun"},{"key":"2690_CR242","doi-asserted-by":"publisher","first-page":"21121","DOI":"10.1002\/cpcb.36","volume":"77","author":"JM Buschhaus","year":"2017","unstructured":"Buschhaus JM, Gibbons AE, Luker KE, Luker GD. Fluorescence Lifetime Imaging of a Caspase-3 Apoptosis Reporter. Curr Protoc Cell Biol. 2017;77:21121\u2013211212. https:\/\/doi.org\/10.1002\/cpcb.36.","journal-title":"Curr Protoc Cell Biol"},{"key":"2690_CR243","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11307-009-0235-y","volume":"12","author":"F Zhou","year":"2010","unstructured":"Zhou F, Xing D, Wu S, Chen WR. Intravital imaging of tumor apoptosis with FRET probes during tumor therapy. Mol Imaging Biol. 2010;12:63\u201370. https:\/\/doi.org\/10.1007\/s11307-009-0235-y.","journal-title":"Mol Imaging Biol"},{"key":"2690_CR244","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.celrep.2017.09.022","volume":"21","author":"M Nobis","year":"2017","unstructured":"Nobis M, Herrmann D, Warren SC, Kadir S, Leung W, Killen M, et al. A RhoA-FRET biosensor mouse for intravital imaging in normal tissue homeostasis and disease contexts. Cell Rep. 2017;21:274\u201388. https:\/\/doi.org\/10.1016\/j.celrep.2017.09.022.","journal-title":"Cell Rep"},{"key":"2690_CR245","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1038\/s41467-021-26614-z","volume":"12","author":"MV Hunter","year":"2021","unstructured":"Hunter MV, Moncada R, Weiss JM, Yanai I, White RM. Spatially resolved transcriptomics reveals the architecture of the tumor-microenvironment interface. Nat Commun. 2021;12:6278. https:\/\/doi.org\/10.1038\/s41467-021-26614-z.","journal-title":"Nat Commun"},{"key":"2690_CR246","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/s41551-025-01423-7","volume":"9","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Schupp JC, Adams T, Clair G, Justet A, Ahangari F, et al. A deep generative model for deciphering cellular dynamics and in silico drug discovery in complex diseases. Nat Biomed Eng. 2025;9:2155\u201380. https:\/\/doi.org\/10.1038\/s41551-025-01423-7.","journal-title":"Nat Biomed Eng"},{"key":"2690_CR247","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, et al. Identification of the tumour transition states occurring during EMT. Nature. 2018;556:463\u20138. https:\/\/doi.org\/10.1038\/s41586-018-0040-3.","journal-title":"Nature"},{"key":"2690_CR248","doi-asserted-by":"publisher","first-page":"e1021","DOI":"10.1002\/cso2.1021","volume":"1","author":"A Katebi","year":"2021","unstructured":"Katebi A, Ramirez D, Lu M. Computational systems-biology approaches for modeling gene networks driving epithelial-mesenchymal transitions. Comput Syst Oncol. 2021;1:e1021. https:\/\/doi.org\/10.1002\/cso2.1021.","journal-title":"Comput Syst Oncol"},{"key":"2690_CR249","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13046-025-03402-x","volume":"44","author":"JL Carstens","year":"2025","unstructured":"Carstens JL, Lovisa S. Epithelial-to-mesenchymal transition drives cancer genomic instability. J Exp Clin Cancer Res. 2025;44:135. https:\/\/doi.org\/10.1186\/s13046-025-03402-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"2690_CR250","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41586-025-08671-2","volume":"640","author":"L Perelli","year":"2025","unstructured":"Perelli L, Zhang L, Mangiameli S, Giannese F, Mahadevan KK, Peng F, et al. Evolutionary fingerprints of epithelial-to-mesenchymal transition. Nature. 2025;640:1083\u201392. https:\/\/doi.org\/10.1038\/s41586-025-08671-2.","journal-title":"Nature"},{"key":"2690_CR251","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/ijms18020274","volume":"18","author":"C Cava","year":"2017","unstructured":"Cava C, Colaprico A, Bertoli G, Graudenzi A, Silva TC, Olsen C, et al. SpidermiR: an R\/bioconductor package for integrative analysis with miRNA Data. Int J Mol Sci. 2017;18:274. https:\/\/doi.org\/10.3390\/ijms18020274.","journal-title":"Int J Mol Sci"},{"key":"2690_CR252","doi-asserted-by":"publisher","first-page":"11665","DOI":"10.1021\/acsomega.2c07989","volume":"8","author":"S Subhadarshini","year":"2023","unstructured":"Subhadarshini S, Markus J, Sahoo S, Jolly MK. Dynamics of epithelial\u2013mesenchymal plasticity: what have single-cell investigations elucidated so far? ACS Omega. 2023;8:11665\u201373. https:\/\/doi.org\/10.1021\/acsomega.2c07989.","journal-title":"ACS Omega"},{"key":"2690_CR253","doi-asserted-by":"publisher","unstructured":"Sahoo S, Ramu S, Nair MG, Pillai M, San Juan BP, Milioli HZ et al. Multi-modal transcriptomic analysis unravels enrichment of hybrid epithelial\/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer. bioRxiv. 2023;2023.09.30.558960. https:\/\/doi.org\/10.1101\/2023.09.30.558960","DOI":"10.1101\/2023.09.30.558960"},{"key":"2690_CR254","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s42003-025-09162-w","volume":"8","author":"A Matsuoka","year":"2025","unstructured":"Matsuoka A, Shien K, Tomida S, Ohki M, Hisamatsu K, Fujiwara R, et al. Single-cell and spatial transcriptomic characterization of pulmonary pleomorphic carcinoma. Commun Biol. 2025;8:1773. https:\/\/doi.org\/10.1038\/s42003-025-09162-w.","journal-title":"Commun Biol"},{"key":"2690_CR255","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171:1611\u2013e162424. https:\/\/doi.org\/10.1016\/j.cell.2017.10.044.","journal-title":"Cell"},{"key":"2690_CR256","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fbioe.2020.00220","volume":"8","author":"P Chakraborty","year":"2020","unstructured":"Chakraborty P, George JT, Tripathi S, Levine H, Jolly MK. Comparative study of transcriptomics-based scoring metrics for the epithelial-hybrid-mesenchymal spectrum. Front Bioeng Biotechnol. 2020;8:220. https:\/\/doi.org\/10.3389\/fbioe.2020.00220.","journal-title":"Front Bioeng Biotechnol"},{"key":"2690_CR257","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/jcm8050725","volume":"8","author":"D Jia","year":"2019","unstructured":"Jia D, Li X, Bocci F, Tripathi S, Deng Y, Jolly MK, et al. Quantifying cancer epithelial-mesenchymal plasticity and its association with stemness and immune response. J Clin Med. 2019;8:725. https:\/\/doi.org\/10.3390\/jcm8050725.","journal-title":"J Clin Med"},{"key":"2690_CR258","doi-asserted-by":"publisher","first-page":"e76535","DOI":"10.7554\/eLife.76535","volume":"11","author":"K Hari","year":"2022","unstructured":"Hari K, Ullanat V, Balasubramanian A, Gopalan A, Jolly MK. Landscape of epithelial-mesenchymal plasticity as an emergent property of coordinated teams in regulatory networks. Elife. 2022;11:e76535. https:\/\/doi.org\/10.7554\/eLife.76535.","journal-title":"Elife"},{"key":"2690_CR259","doi-asserted-by":"publisher","first-page":"111730","DOI":"10.1016\/j.isci.2024.111730","volume":"28","author":"K Hari","year":"2025","unstructured":"Hari K, Harlapur P, Saxena A, Haldar K, Girish A, Malpani T, et al. Low dimensionality of phenotypic space as an emergent property of coordinated teams in biological regulatory networks. iScience. 2025;28:111730. https:\/\/doi.org\/10.1016\/j.isci.2024.111730.","journal-title":"iScience"},{"key":"2690_CR260","doi-asserted-by":"publisher","unstructured":"Bocci F, Jia D, Nie Q, Jolly MK, Onuchic J. Theoretical and computational tools to model multistable gene regulatory networks. Rep Prog Phys Great Br. 2023;86. https:\/\/doi.org\/10.1088\/1361-6633\/acec88.","DOI":"10.1088\/1361-6633\/acec88"},{"key":"2690_CR261","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s42003-025-09326-8","volume":"9","author":"J Slager","year":"2025","unstructured":"Slager J, Gatto F, Frey B, Shi W, Porebski B, Carreras-Puigvert J, et al. A morphology-based machine learning model for scoring epithelial-mesenchymal plasticity using organelle dynamics. Commun Biol. 2025;9:59. https:\/\/doi.org\/10.1038\/s42003-025-09326-8.","journal-title":"Commun Biol"},{"key":"2690_CR262","doi-asserted-by":"publisher","first-page":"62267","DOI":"10.1109\/ACCESS.2025.3558621","volume":"13","author":"G Cicceri","year":"2025","unstructured":"Cicceri G, Di Bella S, Di Franco S, Stassi G, Todaro M, Vitabile S. Deep learning approaches for morphological classification of intestinal organoids. IEEE Access. 2025;13:62267\u201387. https:\/\/doi.org\/10.1109\/ACCESS.2025.3558621.","journal-title":"IEEE Access"},{"key":"2690_CR263","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/7651_2016_346","volume":"1516","author":"J Poleszczuk","year":"2016","unstructured":"Poleszczuk J, Macklin P, Enderling H. Agent-based modeling of cancer stem cell driven solid tumor growth. Methods Mol Biol Clifton N J. 2016;1516:335\u201346. https:\/\/doi.org\/10.1007\/7651_2016_346.","journal-title":"Methods Mol Biol Clifton N J"},{"key":"2690_CR264","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3390\/biom10111561","volume":"10","author":"D Sinha","year":"2020","unstructured":"Sinha D, Saha P, Samanta A, Bishayee A. Emerging concepts of hybrid epithelial-to-mesenchymal transition in cancer progression. Biomolecules. 2020;10:1561. https:\/\/doi.org\/10.3390\/biom10111561.","journal-title":"Biomolecules"},{"key":"2690_CR265","doi-asserted-by":"publisher","first-page":"1684896","DOI":"10.3389\/fonc.2025.1684896","volume":"15","author":"A Alshahrani","year":"2025","unstructured":"Alshahrani A, Alsubait A, Asiri Z, Alghamdi S, Bin Saqyah S, Alqahtani T, et al. Deciphering molecular pathways driving cancer invasion and metastasis: advances and therapeutic prospects. Front Oncol. 2025;15:1684896. https:\/\/doi.org\/10.3389\/fonc.2025.1684896.","journal-title":"Front Oncol"},{"key":"2690_CR266","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1002\/mco2.659","volume":"5","author":"X Wang","year":"2024","unstructured":"Wang X, Xue X, Pang M, Yu L, Qian J, Li X, et al. Epithelial\u2013mesenchymal plasticity in cancer: signaling pathways and therapeutic targets. MedComm. 2024;5:e659. https:\/\/doi.org\/10.1002\/mco2.659.","journal-title":"MedComm"},{"key":"2690_CR267","doi-asserted-by":"publisher","first-page":"111169","DOI":"10.1016\/j.isci.2024.111169","volume":"27","author":"J Verstappe","year":"2024","unstructured":"Verstappe J, Skrypek N, De Coninck J, Soen B, Taminau J, Tatari M, et al. ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition states. iScience. 2024;27:111169. https:\/\/doi.org\/10.1016\/j.isci.2024.111169.","journal-title":"iScience"},{"key":"2690_CR268","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.molonc.2015.10.002","volume":"10","author":"F Andriani","year":"2016","unstructured":"Andriani F, Bertolini G, Facchinetti F, Baldoli E, Moro M, Casalini P, et al. Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells. Mol Oncol. 2016;10:253\u201371. https:\/\/doi.org\/10.1016\/j.molonc.2015.10.002.","journal-title":"Mol Oncol"},{"key":"2690_CR269","doi-asserted-by":"publisher","first-page":"16281","DOI":"10.1073\/pnas.0905653106","volume":"106","author":"G Bertolini","year":"2009","unstructured":"Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, et al. Highly tumorigenic lung cancer CD133\u2009+\u2009cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A. 2009;106:16281\u20136. https:\/\/doi.org\/10.1073\/pnas.0905653106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2690_CR270","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1535-7163.MCT-20-0891","volume":"21","author":"Q Liu","year":"2022","unstructured":"Liu Q, Chen G, Moore J, Guix I, Placantonakis D, Barcellos-Hoff MH. Exploiting canonical TGF\u03b2 signaling in cancer treatment. Mol Cancer Ther. 2022;21:16\u201324. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-0891.","journal-title":"Mol Cancer Ther"},{"key":"2690_CR271","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1159\/000430249","volume":"37","author":"X Ying","year":"2015","unstructured":"Ying X, Sun Y, He P. Bone morphogenetic protein-7 Inhibits EMT-associated genes in breast cancer. Cell Physiol Biochem. 2015;37:1271\u20138. https:\/\/doi.org\/10.1159\/000430249.","journal-title":"Cell Physiol Biochem"},{"key":"2690_CR272","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1111\/j.1349-7006.2009.01301.x","volume":"100","author":"Y-R Na","year":"2009","unstructured":"Na Y-R, Seok S-H, Kim D-J, Han J-H, Kim T-H, Jung H, et al. Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci. 2009;100:2218\u201325. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01301.x.","journal-title":"Cancer Sci"},{"key":"2690_CR273","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41388-019-1047-4","volume":"39","author":"V Veschi","year":"2020","unstructured":"Veschi V, Mangiapane LR, Nicotra A, Di Franco S, Scavo E, Apuzzo T, et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene. 2020;39:987\u20131003. https:\/\/doi.org\/10.1038\/s41388-019-1047-4.","journal-title":"Oncogene"},{"key":"2690_CR274","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40360-025-01080-1","volume":"27","author":"N Rastegar-Pouyani","year":"2026","unstructured":"Rastegar-Pouyani N, Zare H, Rezaei F, Khazen S, Haji Abdolvahab M. Synergistic combination of pirfenidone and paclitaxel suppresses migration and stemness in triple-negative breast cancer: implications of EMT and pluripotency pathways. BMC Pharmacol Toxicol. 2026;27:9. https:\/\/doi.org\/10.1186\/s40360-025-01080-1.","journal-title":"BMC Pharmacol Toxicol"},{"key":"2690_CR275","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrm1261","volume":"4","author":"C Birchmeier","year":"2003","unstructured":"Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol. 2003;4:915\u201325. https:\/\/doi.org\/10.1038\/nrm1261.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2690_CR276","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1158\/1078-0432.CCR-13-1330","volume":"20","author":"I Ca\u00f1adas","year":"2014","unstructured":"Ca\u00f1adas I, Rojo F, Taus \u00c1, Arp\u00ed O, Arum\u00ed-Ur\u00eda M, Pijuan L, et al. Targeting epithelial-to-mesenchymal transition with met inhibitors reverts chemoresistance in small cell lung cancer. Clin Cancer Res. 2014;20:938\u201350. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1330.","journal-title":"Clin Cancer Res"},{"key":"2690_CR277","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2014.11.001","volume":"147","author":"C Neuzillet","year":"2015","unstructured":"Neuzillet C, Tijeras-Raballand A, Cohen R, Cros J, Faivre S, Raymond E, et al. Targeting the TGF\u03b2 pathway for cancer therapy. Pharmacol Ther. 2015;147:22\u201331. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.001.","journal-title":"Pharmacol Ther"},{"key":"2690_CR278","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3810","volume":"11","author":"RJ Akhurst","year":"2012","unstructured":"Akhurst RJ, Hata A. Targeting the TGF\u03b2 signalling pathway in disease. Nat Rev Drug Discov. 2012;11:790\u2013811. https:\/\/doi.org\/10.1038\/nrd3810.","journal-title":"Nat Rev Drug Discov"},{"key":"2690_CR279","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1073\/pnas.0909333107","volume":"107","author":"C Gjerdrum","year":"2010","unstructured":"Gjerdrum C, Tiron C, H\u00f8iby T, Stefansson I, Haugen H, Sandal T, et al. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci U S A. 2010;107:1124\u20139. https:\/\/doi.org\/10.1073\/pnas.0909333107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2690_CR280","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4161\/cbt.8.7.7923","volume":"8","author":"J-BM Koorstra","year":"2009","unstructured":"Koorstra J-BM, Karikari CA, Feldmann G, Bisht S, Rojas PL, Offerhaus GJA, et al. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target. Cancer Biol Ther. 2009;8:618\u201326. https:\/\/doi.org\/10.4161\/cbt.8.7.7923.","journal-title":"Cancer Biol Ther"},{"key":"2690_CR281","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","volume":"19","author":"LA Byers","year":"2013","unstructured":"Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res. 2013;19:279\u201390. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1558.","journal-title":"Clin Cancer Res"},{"key":"2690_CR282","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ncb1173","volume":"6","author":"BP Zhou","year":"2004","unstructured":"Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004;6:931\u201340. https:\/\/doi.org\/10.1038\/ncb1173.","journal-title":"Nat Cell Biol"},{"key":"2690_CR283","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3892\/ijo.2019.4716","volume":"54","author":"X Jin","year":"2019","unstructured":"Jin X, Luan H, Chai H, Yan L, Zhang J, Wang Q, et al. Netrin\u20131 interference potentiates epithelial\u2013to\u2013mesenchymal transition through the PI3K\/AKT pathway under the hypoxic microenvironment conditions of non\u2013small cell lung cancer. Int J Oncol. 2019;54:1457\u201365. https:\/\/doi.org\/10.3892\/ijo.2019.4716.","journal-title":"Int J Oncol"},{"key":"2690_CR284","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41586-023-06367-z","volume":"620","author":"PA Cassier","year":"2023","unstructured":"Cassier PA, Navaridas R, Bellina M, Rama N, Ducarouge B, Hernandez-Vargas H, et al. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer. Nature. 2023;620:409\u201316. https:\/\/doi.org\/10.1038\/s41586-023-06367-z.","journal-title":"Nature"},{"key":"2690_CR285","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-13-2613","volume":"20","author":"L Li","year":"2014","unstructured":"Li L, Han R, Xiao H, Lin C, Wang Y, Liu H, et al. Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. Clin Cancer Res. 2014;20:2714\u201326. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2613.","journal-title":"Clin Cancer Res"},{"key":"2690_CR286","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1126\/science.1191880","volume-title":"Btbd7 regulates epithelial cell dynamics and branching morphogenesis","author":"T Onodera","year":"2010","unstructured":"Onodera T, Sakai T, Hsu JC, Matsumoto K, Chiorini JA, Yamada KM. Btbd7 regulates epithelial cell dynamics and branching morphogenesis. Volume 329. New York, N.Y.: Science; 2010. pp. 562\u20135. https:\/\/doi.org\/10.1126\/science.1191880."},{"key":"2690_CR287","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3727\/096504016X14772349843854","volume":"25","author":"L-Z Fang","year":"2017","unstructured":"Fang L-Z, Zhang J-Q, Liu L, Fu W-P, Shu J-K, Feng J-G, et al. Silencing of Btbd7 Inhibited Epithelial-Mesenchymal Transition and Chemoresistance in CD133+ Lung Carcinoma A549 Cells. oncol res. 2017;25:819\u201329. https:\/\/doi.org\/10.3727\/096504016X14772349843854.","journal-title":"oncol res"},{"key":"2690_CR288","doi-asserted-by":"publisher","first-page":"130901","DOI":"10.1016\/j.bbagen.2026.130901","volume":"1870","author":"H Yan","year":"2026","unstructured":"Yan H, Wang X, Mo Y, Huang Y, Fu Z, Xie L. Targeting the IGF1\/Twist1 axis: A novel mechanism for \u03b2-elemene-induced anoikis and EMT inhibition in breast cancer cells. Biochimica et Biophysica Acta (BBA) -. Gen Subj. 2026;1870:130901. https:\/\/doi.org\/10.1016\/j.bbagen.2026.130901.","journal-title":"Gen Subj"},{"key":"2690_CR289","doi-asserted-by":"publisher","first-page":"157735","DOI":"10.1016\/j.phymed.2025.157735","volume":"150","author":"M Li","year":"2026","unstructured":"Li M, Yang J, Wang K, Zhu A, Yin H, Li Z, et al. Taxifolin promotes glioma stem cell differentiation via CYP1B1-mediated EMT suppression. Phytomedicine. 2026;150:157735. https:\/\/doi.org\/10.1016\/j.phymed.2025.157735.","journal-title":"Phytomedicine"},{"key":"2690_CR290","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, DeBerardinis RJ. Understanding the Intersections between metabolism and cancer biology. Cell. 2017;168:657\u201369. https:\/\/doi.org\/10.1016\/j.cell.2016.12.039.","journal-title":"Cell"},{"key":"2690_CR291","doi-asserted-by":"publisher","first-page":"e115144","DOI":"10.1371\/journal.pone.0115144","volume":"9","author":"DB Ulanet","year":"2014","unstructured":"Ulanet DB, Couto K, Jha A, Choe S, Wang A, Woo H-K, et al. Mesenchymal phenotype predisposes lung cancer cells to impaired proliferation and redox stress in response to glutaminase inhibition. PLoS ONE. 2014;9:e115144. https:\/\/doi.org\/10.1371\/journal.pone.0115144.","journal-title":"PLoS ONE"},{"key":"2690_CR292","doi-asserted-by":"publisher","first-page":"5448","DOI":"10.3390\/cancers15225448","volume":"15","author":"A Sebesty\u00e9n","year":"2023","unstructured":"Sebesty\u00e9n A, Lisanti MP, Ozsvari B. Novel metabolic approaches targeting cancer cells. Cancers (Basel). 2023;15:5448. https:\/\/doi.org\/10.3390\/cancers15225448.","journal-title":"Cancers (Basel)"},{"key":"2690_CR293","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.trecan.2020.06.005","volume":"6","author":"V Ramesh","year":"2020","unstructured":"Ramesh V, Brabletz T, Ceppi P. Targeting EMT in Cancer with repurposed metabolic inhibitors. Trends Cancer. 2020;6:942\u201350. https:\/\/doi.org\/10.1016\/j.trecan.2020.06.005.","journal-title":"Trends Cancer"},{"key":"2690_CR294","doi-asserted-by":"publisher","first-page":"35783","DOI":"10.1038\/srep35783","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang G, Cao R, Wang Y, Qian G, Dan HC, Jiang W, et al. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPAR\u03b3 signalling pathway. Sci Rep. 2016;6:35783. https:\/\/doi.org\/10.1038\/srep35783.","journal-title":"Sci Rep"},{"key":"2690_CR295","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3390\/biomedicines10081837","volume":"10","author":"M-Y Song","year":"2022","unstructured":"Song M-Y, Lee D-Y, Yun S-M, Kim E-H. GLUT3 Promotes epithelial-mesenchymal transition via TGF-\u03b2\/JNK\/ATF2 signaling pathway in colorectal cancer cells. Biomedicines. 2022;10:1837. https:\/\/doi.org\/10.3390\/biomedicines10081837.","journal-title":"Biomedicines"},{"key":"2690_CR296","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1038\/onc.2015.444","volume":"35","author":"M Ruscetti","year":"2016","unstructured":"Ruscetti M, Dadashian EL, Guo W, Quach B, Mulholland DJ, Park JW, et al. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. Oncogene. 2016;35:3781\u201395. https:\/\/doi.org\/10.1038\/onc.2015.444.","journal-title":"Oncogene"},{"key":"2690_CR297","doi-asserted-by":"publisher","first-page":"64","DOI":"10.20517\/cdr.2021.105","volume":"5","author":"B Biersack","year":"2022","unstructured":"Biersack B, Nitzsche B, H\u00f6pfner M. HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer. Cancer Drug Resist Alhambra Calif. 2022;5:64\u201379. https:\/\/doi.org\/10.20517\/cdr.2021.105.","journal-title":"Cancer Drug Resist Alhambra Calif"},{"key":"2690_CR298","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fmolb.2020.00036","volume":"7","author":"S Dr\u00e1pela","year":"2020","unstructured":"Dr\u00e1pela S, Bouchal J, Jolly MK, Culig Z, Sou\u010dek K. ZEB1: A critical regulator of cell plasticity, dna damage response, and therapy resistance. Front Mol Biosci. 2020;7:36. https:\/\/doi.org\/10.3389\/fmolb.2020.00036.","journal-title":"Front Mol Biosci"},{"key":"2690_CR299","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.3390\/biomedicines13122950","volume":"13","author":"E Simanovich","year":"2025","unstructured":"Simanovich E, Oyelami F, Brockmeyer P, Rahat MA. The Anti-EMMPRIN monoclonal antibody hMR18-mAb induces tumor dormancy and inhibits the EMT process in human carcinoma cell lines co-cultured with macrophages. Biomedicines. 2025;13:2950. https:\/\/doi.org\/10.3390\/biomedicines13122950.","journal-title":"Biomedicines"},{"key":"2690_CR300","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.drup.2010.07.001","volume":"13","author":"Z Wang","year":"2010","unstructured":"Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, et al. Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist Updat. 2010;13:109\u201318. https:\/\/doi.org\/10.1016\/j.drup.2010.07.001.","journal-title":"Drug Resist Updat"},{"key":"2690_CR301","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.18632\/oncotarget.2714","volume":"6","author":"J Ma","year":"2015","unstructured":"Ma J, Fang B, Zeng F, Ma C, Pang H, Cheng L, et al. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Oncotarget. 2015;6:1740\u20139. https:\/\/doi.org\/10.18632\/oncotarget.2714.","journal-title":"Oncotarget"},{"key":"2690_CR302","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-023-01383-x","volume":"8","author":"Z-D Shi","year":"2023","unstructured":"Shi Z-D, Pang K, Wu Z-X, Dong Y, Hao L, Qin J-X, et al. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Sig Transduct Target Ther. 2023;8:113. https:\/\/doi.org\/10.1038\/s41392-023-01383-x.","journal-title":"Sig Transduct Target Ther"},{"key":"2690_CR303","doi-asserted-by":"publisher","first-page":"188997","DOI":"10.1016\/j.bbcan.2023.188997","volume":"1878","author":"Z Li","year":"2023","unstructured":"Li Z, Yin P. Tumor microenvironment diversity and plasticity in cancer multidrug resistance. Biochim et Biophys Acta (BBA) - Reviews Cancer. 2023;1878:188997. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188997.","journal-title":"Biochim et Biophys Acta (BBA) - Reviews Cancer"},{"key":"2690_CR304","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/ITT.S291767","volume":"10","author":"R Bughda","year":"2021","unstructured":"Bughda R, Dimou P, D\u2019Souza RR, Klampatsa A. Fibroblast activation protein (FAP)-Targeted CAR-T Cells: launching an attack on tumor stroma. Immunotargets Ther. 2021;10:313\u201323. https:\/\/doi.org\/10.2147\/ITT.S291767.","journal-title":"Immunotargets Ther"},{"key":"2690_CR305","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-024-01099-2","volume":"32","author":"Z Cao","year":"2025","unstructured":"Cao Z, Quazi S, Arora S, Osellame LD, Burvenich IJ, Janes PW, et al. Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects. J Biomed Sci. 2025;32:7. https:\/\/doi.org\/10.1186\/s12929-024-01099-2.","journal-title":"J Biomed Sci"},{"key":"2690_CR306","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu F, Yang J, Liu J, Wang Y, Mu J, Zeng Q, et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Sig Transduct Target Ther. 2021;6:218. https:\/\/doi.org\/10.1038\/s41392-021-00641-0.","journal-title":"Sig Transduct Target Ther"},{"key":"2690_CR307","doi-asserted-by":"publisher","first-page":"1617487","DOI":"10.3389\/or.2025.1617487","volume":"19","author":"HH Lee","year":"2025","unstructured":"Lee HH, Al-Ogaili Z. Fibroblast activation protein and the tumour microenvironment: challenges and therapeutic opportunities. Oncol Rev. 2025;19:1617487. https:\/\/doi.org\/10.3389\/or.2025.1617487.","journal-title":"Oncol Rev"},{"key":"2690_CR308","doi-asserted-by":"publisher","first-page":"756334","DOI":"10.3389\/fonc.2021.756334","volume":"11","author":"J Liang","year":"2021","unstructured":"Liang J, Wang S, Zhang G, He B, Bie Q, Zhang B. A New antitumor direction: tumor-specific endothelial cells. Front Oncol. 2021;11:756334. https:\/\/doi.org\/10.3389\/fonc.2021.756334.","journal-title":"Front Oncol"},{"key":"2690_CR309","doi-asserted-by":"publisher","first-page":"10099","DOI":"10.2147\/OTT.S224053","volume":"12","author":"D Xu","year":"2019","unstructured":"Xu D, Li J, Li R-Y, Lan T, Xiao C, Gong P. PD-L1 Expression is regulated By NF-\u03baB during EMT signaling in gastric carcinoma. Onco Targets Ther. 2019;12:10099\u2013105. https:\/\/doi.org\/10.2147\/OTT.S224053.","journal-title":"Onco Targets Ther"},{"key":"2690_CR310","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.7150\/ijms.54239","volume":"18","author":"R Shrestha","year":"2021","unstructured":"Shrestha R, Bridle KR, Crawford DHG, Jayachandran A. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-\u03b21-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. Int J Med Sci. 2021;18:2466\u201379. https:\/\/doi.org\/10.7150\/ijms.54239.","journal-title":"Int J Med Sci"},{"key":"2690_CR311","doi-asserted-by":"publisher","first-page":"e1268","DOI":"10.1093\/oncolo\/oyad188","volume":"28","author":"M Fallon","year":"2023","unstructured":"Fallon M, Sopata M, Dragon E, Brown MT, Viktrup L, West CR, et al. A Randomized placebo-controlled trial of the anti-nerve growth factor antibody tanezumab in subjects with cancer pain due to bone metastasis. Oncologist. 2023;28:e1268\u201378. https:\/\/doi.org\/10.1093\/oncolo\/oyad188.","journal-title":"Oncologist"},{"key":"2690_CR312","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/MPA.0000000000001090","volume":"47","author":"JL Saloman","year":"2018","unstructured":"Saloman JL, Singhi AD, Hartman DJ, Normolle DP, Albers KM, Davis BM. Systemic Depletion of nerve growth factor inhibits disease progression in a genetically engineered model of pancreatic ductal adenocarcinoma. Pancreas. 2018;47:856\u201363. https:\/\/doi.org\/10.1097\/MPA.0000000000001090.","journal-title":"Pancreas"},{"key":"2690_CR313","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.3390\/cancers16244260","volume":"16","author":"I Garajov\u00e1","year":"2024","unstructured":"Garajov\u00e1 I, Giovannetti E. Targeting Perineural Invasion in Pancreatic Cancer. Cancers (Basel). 2024;16:4260. https:\/\/doi.org\/10.3390\/cancers16244260.","journal-title":"Cancers (Basel)"},{"key":"2690_CR314","doi-asserted-by":"publisher","first-page":"113206","DOI":"10.1016\/j.yexcr.2022.113206","volume":"417","author":"S Wang","year":"2022","unstructured":"Wang S, Nie L, Song Y, Zhang F, Chen X, Shi W, et al. Corrigendum to Neurturin promotes tumor cell motility and angiogenesis in colorectal cancer [Exp. Cell Res. 413 (2022) 113049]. Exp Cell Res. 2022;417:113206. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113206.","journal-title":"Exp Cell Res"},{"key":"2690_CR315","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature25492","volume":"554","author":"DVF Tauriello","year":"2018","unstructured":"Tauriello DVF, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, et al. TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis. Nature. 2018;554:538\u201343. https:\/\/doi.org\/10.1038\/nature25492.","journal-title":"Nature"},{"key":"2690_CR316","doi-asserted-by":"publisher","first-page":"ltaf009","DOI":"10.1093\/immadv\/ltaf009","volume":"5","author":"R Gomes Alves Martins","year":"2024","unstructured":"Gomes Alves Martins R, Tekin MM, Cragg MS, Roghanian A. Therapeutic targeting of tumour-associated macrophage receptors. Immunotherapy Adv. 2024;5:ltaf009. https:\/\/doi.org\/10.1093\/immadv\/ltaf009.","journal-title":"Immunotherapy Adv"},{"key":"2690_CR317","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3892\/ijo.2024.5648","volume":"64","author":"P Su","year":"2024","unstructured":"Su P, Li O, Ke K, Jiang Z, Wu J, Wang Y, et al. Targeting tumor\u2013associated macrophages: Critical players in tumor progression and therapeutic strategies (Review). Int J Oncol. 2024;64:60. https:\/\/doi.org\/10.3892\/ijo.2024.5648.","journal-title":"Int J Oncol"},{"key":"2690_CR318","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.3390\/cancers12092626","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Jia A, Bi Y, Wang Y, Yang Q, Cao Y, et al. Targeting myeloid-derived suppressor cells in cancer immunotherapy. Cancers. 2020;12:2626. https:\/\/doi.org\/10.3390\/cancers12092626.","journal-title":"Cancers"},{"key":"2690_CR319","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.phrs.2018.07.019","volume":"135","author":"N Griffin","year":"2018","unstructured":"Griffin N, Faulkner S, Jobling P, Hondermarck H. Targeting neurotrophin signaling in cancer: the renaissance. Pharmacol Res. 2018;135:12\u20137. https:\/\/doi.org\/10.1016\/j.phrs.2018.07.019.","journal-title":"Pharmacol Res"},{"key":"2690_CR320","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.3390\/curroncol29110640","volume":"29","author":"F Bruno","year":"2022","unstructured":"Bruno F, Arcuri D, Vozzo F, Malvaso A, Montesanto A, Maletta R. Expression and signaling pathways of nerve growth factor (NGF) and Pro-NGF in breast cancer: a systematic review. Curr Oncol Tor Ont. 2022;29:8103\u201320. https:\/\/doi.org\/10.3390\/curroncol29110640.","journal-title":"Curr Oncol Tor Ont"},{"key":"2690_CR321","doi-asserted-by":"publisher","first-page":"8067","DOI":"10.1074\/jbc.M113.513762","volume":"289","author":"PA Forsyth","year":"2014","unstructured":"Forsyth PA, Krishna N, Lawn S, Valadez JG, Qu X, Fenstermacher DA, et al. p75 neurotrophin receptor cleavage by \u03b1- and \u03b3-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells. J Biol Chem. 2014;289:8067\u201385. https:\/\/doi.org\/10.1074\/jbc.M113.513762.","journal-title":"J Biol Chem"},{"key":"2690_CR322","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/onc.2015.199","volume":"35","author":"BY Ahn","year":"2016","unstructured":"Ahn BY, Saldanha-Gama RFG, Rahn JJ, Hao X, Zhang J, Dang N-H, et al. Glioma invasion mediated by the p75 neurotrophin receptor (p75(NTR)\/CD271) requires regulated interaction with PDLIM1. Oncogene. 2016;35:1411\u201322. https:\/\/doi.org\/10.1038\/onc.2015.199.","journal-title":"Oncogene"},{"key":"2690_CR323","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/labinvest.2016.109","volume":"96","author":"A Nomura","year":"2016","unstructured":"Nomura A, Majumder K, Giri B, Dauer P, Dudeja V, Roy S, et al. Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer. Lab Invest. 2016;96:1268\u201378. https:\/\/doi.org\/10.1038\/labinvest.2016.109.","journal-title":"Lab Invest"},{"key":"2690_CR324","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2017.02.005","volume":"31","author":"B Boilly","year":"2017","unstructured":"Boilly B, Faulkner S, Jobling P, Hondermarck H. Nerve dependence: from regeneration to cancer. Cancer Cell. 2017;31:342\u201354. https:\/\/doi.org\/10.1016\/j.ccell.2017.02.005.","journal-title":"Cancer Cell"},{"key":"2690_CR325","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2174\/1570159X14666160121114854","volume":"14","author":"H-L Rabben","year":"2016","unstructured":"Rabben H-L, Zhao C-M, Hayakawa Y, Wang C, Chen T. Vagotomy and gastric tumorigenesis. CN. 2016;14:967\u201372. https:\/\/doi.org\/10.2174\/1570159X14666160121114854.","journal-title":"CN"},{"key":"2690_CR326","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1021\/acsbiomaterials.4c00445","volume":"10","author":"HB Aydin","year":"2024","unstructured":"Aydin HB, Ozcelikkale A, Acar A. Exploiting matrix stiffness to overcome drug resistance. ACS Biomater Sci Eng. 2024;10:4682\u2013700. https:\/\/doi.org\/10.1021\/acsbiomaterials.4c00445.","journal-title":"ACS Biomater Sci Eng"},{"key":"2690_CR327","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","volume":"15","author":"Z Mai","year":"2024","unstructured":"Mai Z, Lin Y, Lin P, Zhao X, Cui L. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death Dis. 2024;15:307. https:\/\/doi.org\/10.1038\/s41419-024-06697-4.","journal-title":"Cell Death Dis"},{"key":"2690_CR328","doi-asserted-by":"publisher","unstructured":"Hu J, Tang Z, Beeraka NM, Xu R, Liu J, Zhao X, et al. Multi-pathway therapeutics in colorectal cancer: targeting EMT, CSCs, and non-apoptotic cell death for drug resistance reversal. J Drug Target. 2025;1\u201322. https:\/\/doi.org\/10.1080\/1061186X.2025.2600679.","DOI":"10.1080\/1061186X.2025.2600679"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02690-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02690-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02690-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:45:47Z","timestamp":1784763947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02690-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":328,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2690"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02690-x","relation":{"references":[{"id-type":"doi","id":"10.3892\/ol.2018.9854","asserted-by":"subject"}]},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"181"}}